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Abstract
Modelling haematopoietic stem cells (HSCs) mathematically allows us to
probe their behaviour, test hypotheses and make predictions. HSCs are
essential and elusive; despite many recent advances much remains unknown,
including how the microenvironment (niche) influences HSC behaviour, and
the nature of complex interactions between HSCs, the niche and disease.
This thesis comprises three sections. In the first we present new methods
for the analysis of ODE systems that allow us to characterise steady state
properties such as the probability of a state being stable (over some param-
eter range). We apply these methods to models of stem cell dynamics that
di↵er in the form of regulation (feedback) imposed on the system and study
the steady states of these systems.
Competition within the niche between HSCs and invading cancer cells dis-
rupts the system. In the second section we model this using ODEs that
describe the population dynamics of cellular species from an ecological per-
spective. From the analysis of two models di↵ering in their treatment of the
niche, using Bayesian inference, we find that maintaining a viable HSC pop-
ulation is necessary and almost su cient in order to outcompete leukaemia
and restore healthy haematopoiesis.
In the third section we extend the analysis of interactions between HSCs,
leukaemia and the niche: performing a comparison of three models that de-
scribe the dynamics of chronic myeloid leukaemia. We study heterogeneous
data from a clinical trial of the disease. All models fit these data, but do so
in di↵erent ways. One model is discarded due to its unrealistic predictions,
suggesting that direct competition between species is important. Each of
the remaining two models makes testable predictions, but validating these
is at current experimental limits. In the future, the results presented will
aid experimental design and provide a framework from which to identify
new therapeutic targets for haematopoietic diseases.
Isn’t this enough? Just this world? Just this beautiful, complex,
wonderfully unfathomable world?
– Tim Minchin
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Introduction
Understanding the biology of haematopoietic stem cells (HSCs) is of great
importance. HSCs control the production of all the di↵erent types of blood
cell through tightly orchestrated processes; by explaining these processes
we will learn more about the haematopoietic system and about cell fate
choice, cellular regulation and other basic mechanisms. This will have an
impact on biomedical research: most directly for haematological disorders,
including leukaemia. There is a further case for studying HSCs as a model
for other (stem) cell systems, given that haematopoiesis is relatively well
characterised and its outputs (blood cells) are abundant and easy to mea-
sure.
In Chapter 2 of this thesis, the biology of HSCs is presented with a descrip-
tion of how they are specified and regulated. The microenvironment re-
2
3quired by HSCs to function correctly, known as the stem cell niche, is intro-
duced and our knowledge about it summarised. We also discuss leukaemia
and the idea of competition within the niche. This covers all of the biolog-
ical topics that will be the focus of this work.
We seek to learn about HSCs using models and in Chapter 3 we describe the
mathematical framework upon which we base this theoretical investigation.
The central concepts used are taken from ecology; these are presented and
placed within a historical context. In order to motivate the models that
are subsequently developed, we give an overview of di↵erent strategies that
could be suitable for modelling HSCs, with examples from current literature.
In Chapter 4 we develop methods for stability analysis in order to study
models of stem cell niche dynamics. We develop a family of deterministic
models for the purposes of this analysis and use them to demonstrate how
we can study the linear stability of the steady states of such models in a
general, probabilistic way.
Two new models are studied in Chapter 5, for the purpose of understanding
how competition plays out in the niche. Specifically, we look at the inter-
actions between HSCs and leukaemia stem cells (LSCs). The new models
are based on similar assumptions to those of Chapter 4, but with the ex-
tension that they now include a description of cancer in the niche. They
also treat interactions with the niche di↵erently. We study these models
using a qualitative inference framework that allows us to search globally for
behaviour that we wish to observe, namely, the eradication of leukaemia
from the niche. We describe conditions under which this is possible and
4discuss them in an ecological context.
Chapter 6 continues our study of the population biology of HSCs and LSCs,
applied here to the specific example of chronic myeloid leukaemia. We
seek to describe data from patients undergoing treatment for the disease
using three models, one from the previous chapter and two from literature.
Adopting a model comparison approach, we look at where each model can
or cannot explain the data and find that although all of the models can
explain the data, significant di↵erences in how they do so arise. This leads
us to reject one of the models and propose di↵erent mechanisms for disease
progression based on the other two.
In the final chapter we draw together the various themes of competition,
stability and survival in the niche with regards to systems of stem cells and
we make some general conclusions. We also discuss directions for future
study.
Two
Background: haematopoiesis,
leukaemia and the stem cell
niche
2.1 Overview
Haematopoietic stem cells (HSCs) are central to this work; in this chapter
they are presented and the biology pertinent to their function and main-
tenance is described. We discuss the challenges of identifying HSCs and
describe briefly how they are regulated. We go on to introduce the concept
of a stem cell niche, and the knowledge that we have about the niche is
described, along with its limitations. We discuss disease caused by muta-
tions or environmental changes in the haematopoietic system, in particular
5
2.2. Haematopoietic stem cells 6
leukaemia. We give an outline of the ways in which leukaemia and leukaemia
stem cells (LSCs) can interact with HSCs and the niche.
2.2 Haematopoietic stem cells
Driven by HSCs, haematopoiesis – or blood formation – occurs in all ver-
tebrates and accounts for the production and renewal of all types of blood
cell throughout the lifetime of an animal. In development, this process be-
gins in the yolk sac, the aorta-gonad-mesonephros region and the placenta
where haematopoietic progenitor cells are first found to be present (Lanza,
2009). They subsequently move through the fetal liver and, just before
birth, migrate to the bone marrow (Mikkola & Orkin, 2006). The bone
marrow remains thereafter the dominant site of haematopoiesis throughout
the lifetime of the individual.
HSCs are responsible for the production of blood cells and can be pictured
as the root of a tree-like structure where branching points mark lineage
choices: early on the lymphoid and myeloid lineages split, followed by sub-
sequent splits that further restrict each lineage until each branch produces
one terminally di↵erentiated (and specialised) cell type, such as an erythro-
cyte, B cell, T cell or neutrophil. A representation of the haematopoietic
tree is shown in Figure 2.1.
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Figure 2.1: Haematopoiesis: all blood cells are produced from HSCs in a
hierarchical process. Representation of haematopoiesis in the bone marrow
showing some of the possible di↵erent cell populations (commonly identi-
fied using cell surface markers). Through a number of di↵erentiation and
branching steps (moving from top to bottom), HSCs lose their stemness and
become specialised. Stem/progenitor cell species are shown in blue and the
di↵erent specialised blood cells are shown in other colours. Self-renewal
arrows for the HSC populations denote the long term (indefinite) repopula-
tion potential of these cells. Dashed arrows denote putative transitions that
could occur instead of (or as well as) the accepted transitions shown in bold.
Abbreviations: LT, long term; ST, short term; MPP, multipotent progeni-
tor; CMP, common myeloid progenitor; CLP (CMLP), common lymphoid
progenitor (common myeloid-lymphoid progenitor); MEP, megakaryocyte-
erythroid progenitor; GMP, granulocyte-macrophage progenitor; NK, nat-
ural killer. The granulocytes are a sub-population of specialised cells that
include mast cells, basophils, eosinophils and neutrophils.
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2.2.1 Haematopoietic stem cell specification
The property of stemness defines an HSC. The three main qualities that
are encompassed by this term are the ability
• to generate multiple cell types through asymmetric division,
• to regenerate tissue when transplanted and
• to quiesce, enabling a long life span (Martinez-Agosto et al., 2007).
However, qualifying the stemness of a cell is not straightforward (Mikkers
& Frise´n, 2005; Potten & Loe✏er, 1990). The long-term follow-up required
to prove that the cell can regenerate tissue successfully, coupled with the
heterogeneity of most (if not all) cell populations means that we cannot
ever say with certainty that a particular cell is an HSC. Location can also
influence and conflate HSC determination (Grassinger et al., 2010). As such,
it is impossible to observe an HSC directly; the best we can do is to define as
HSCs the population we obtain by sorting cells using the best available cell
surface markers, and keep in mind that probably only a subpopulation of
these are actually HSCs. In the work that follows, we adopt these standards:
we refer to the haematopoietic cell population that is identified as being
most primitive as HSCs. It is worth keeping in mind, however, that HSCs
have never truly been isolated. The elusive nature of these stem cells means
that analyses can be di cult and at times rely on inaccurate assumptions.
Haematopoietic cells that are Lineage  lack expression of cell markers which
define various lineage-committed cell types. The combination of Lineage 
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plus positive expression of cell-surface markers Sca-1 and c-Kit defines a
multipotent haematopoietic cell population (Okada et al., 1992; Spangrude
et al., 1988). Within this population, to distinguish between multipotent
progenitor cells, short-term HSCs and long-term HSCs, cluster of di↵erenti-
ation (CD) markers including CD34, CD48 and CD150 can be used (Wang
& Wagers, 2011).
2.2.2 Haematopoietic stem cell regulation
There are a number of signalling pathways that are known to play important
roles in the specification and maintenance of HSC function and location.
Two key regulatory pathways – those of Wnt and Notch signalling – are
briefly described here. These molecular mechanisms that underpin cellular
function are introduced to help to explain the context of cells within the
HSC niche.
The wingless type protein family (Wnt) pathways (canonical and non-
canonical) exert an influence over haematopoiesis (Austin et al., 1997; Flem-
ing et al., 2008). The canonical Wnt pathway is mediated by the Wnt re-
ceptor Frizzled on the cell membrane and ultimately a↵ects the expression
and location of  -catenin, which can translocate to the nucleus and lead
to the transcription of target genes, including some that perform functions
targeting self renewal. Although there is some controversy over the exact
role of Wnt in HSC self renewal regulation, both the level and the duration
of the signal seem to be important (Malhotra & Kincade, 2009; Staal &
Luis, 2010). Non-canonical Wnt signalling has been shown to play a role in
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maintaining quiescence in HSCs (Sugimura et al., 2012).
The Notch signalling pathway is crucially involved in maintaining HSC self
renewal potential (Duncan et al., 2005; Karanu et al., 2000; Morrison et al.,
1997). Notch also influences location: osteoblasts that express the Notch
ligand Jagged-1 regulate HSCs since stimulated osteoblast production in-
creases the number of HSCs found in the niche (Calvi et al., 2003; Zhang
et al., 2003). There also remain important unanswered questions regarding
this pathway including whether Notch signalling is required under homeo-
static conditions and to what extent the crosstalk between Notch and other
pathways influences haematopoiesis (Duncan et al., 2005; Renstrom et al.,
2010).
These pathways appear to be amongst the most important with regard to
HSCs, however the topic is far from exhausted. See Blank et al. (2008) for
review and (for example) (Smith-Berdan et al., 2011; Yilmaz et al., 2006)
for further discussion of pathways involved in the regulation of HSCs.
2.3 The haematopoietic stem cell niche
Understanding the niche in which HSCs reside has been shown to be crucial
in order to understand HSCs. Here we describe what is known about HSC-
niche interactions and discuss open questions and challenges.
The niche of an organism is defined as the space it occupies within its
habitat and the resources that it requires to function. This definition is
applicable to cellular species in addition to complete organisms. There
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exists a mammalian niche – found within the bone marrow – that is occupied
by HSCs. First introduced by Schofield (1978), our understanding of the
HSC niche has grown dramatically in recent years.
In 2003, it was shown that osteoblasts regulate HSCs in the niche (Calvi
et al., 2003; Zhang et al., 2003). Osteoblasts reside in the endosteum –
the area between bone and bone marrow, thus suggesting that the endos-
teum could be an HSC niche location. Using cell surface markers (Kiel
et al., 2005), and then using two-photon and confocal microscopy (Lo Celso
et al., 2009a), it was demonstrated that HSCs are indeed found near to ves-
sels and/or osteoblasts and the endosteal surface. The question of whether
HSCs are located at or near the endosteum remains under debate, with ev-
idence from Kiel et al. (2009) suggesting that HSCs reside near but not at
the endosteum. An important role in defining HSC niches is also played by
perivascular cells (residing at the periphery of blood vessels) (Kiel & Morri-
son, 2008; Kiel et al., 2005). Ding et al. (2012) suggest that HSCs occupy a
perivascular niche with support from endothelial cells but without support
from osteoblasts, given their work where HSC frequency and function were
studied following conditional depletion of the stem cell factor ligand from
di↵erent cell types.
At times, it seems that HSC scientists are in danger of becoming as en-
trenched in their disparate beliefs about the true location of the niche as
the stem cells are themselves in their niches. Whether there are two distinct
niches: endosteal and perivascular, or whether there is only one location
that we are yet to isolate is an open question (Morrison & Spradling, 2008).
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Either way, self renewal capacity and other HSC attributes will be a↵ected
by which niche (or part of the niche) an HSC is found in (Haylock et al.,
2007). If it is the case that both endosteal and perivascular niches coexist,
it has been proposed that dormant HSCs might reside in an endosteal niche,
and active (cycling) HSCs in a perivascular niche (Wilson et al., 2007).
In addition to the endosteal vs. perivascular niche question, the influence
of other cell types on HSC niche maintenance is also important. The pro-
genitor cells that are progeny of HSCs can directly exert an influence on the
niche (Hsu & Fuchs, 2012). Macrophages play a role in niche maintenance,
as do mesenchymal stem cells (directly, in addition to the role they play by
producing osteoblasts) (Ehninger & Trumpp, 2011; Me´ndez-Ferrer et al.,
2010), as do CXCL12-abudant reticular cells (Sugiyama et al., 2006). The
picture we have is thus complicated and far from complete. The complexity
increases further when we consider functional aspects of the niche: how is
HSC dormancy controlled? (Trumpp et al., 2010) and is the niche solely a
place of quiescence or does it also allow for HSC self renewal? (Wilson &
Trumpp, 2006)
In ecology, niches are commonly studied in order to better understand
species’ behaviour both in isolation and when interacting with other species.
Here the definition of the niche changes slightly from its biological use, shift-
ing towards a functional definition that is more broad than the biological
one.
In the modelling work that follows, because of these unanswered questions
regarding how the niche is defined (both competing biological descriptions
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and biological versus ecological descriptions), choice of the niche definition
will depend on the goal of the model and will need to be justified, in concor-
dance with choosing its functional extent. It could be defined as the area in
which an HSC is in direct contact with a niche-supporting cell, or the extent
of influence of all extrinsic niche signals on HSCs, or (most widely) as the
volume of the whole inner bone marrow cavity. In the case of each model
introduced, the assumptions surrounded niche definition will be explained
and justified.
2.4 Leukaemia
Leukaemias are haematological malignancies, that is, cancers of the blood
system. Leukaemias can be characterised based on the haematopoietic
branch they primarily a↵ect (myeloid/lymphoid) and the speed of their pro-
gression (acute/chronic). In all cases, normal haematopoiesis is disrupted
by an abnormal expansion of some haematopoietic cell type. Leukaemias
present a serious health concern, particularly among older people: 1 in
72 people will be diagnosed with leukaemia during their lifetime and the
age-adjusted death rate is 7.1 per 100,000 people per year [based on U.S.
mortality rates from 2000 – 2010] (Howlader et al., 2013).
In Chapter 6 of this thesis, treatment of a particular leukaemia – chronic
myeloid leukaemia (CML) – is studied. CML is characterised by a chro-
mosomal translocation: t(9;22)-(q34;q11) in up to 95% of patients with the
disease (Epstein et al., 1999). This creates a hybrid gene called BCR-ABL
that is strongly associated with the disease, and molecular therapy via ty-
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rosine kinase inhibitors that selectively target the BCR-ABL protein has
proven to be very successful and indeed pioneered targeted cancer therapy
(Muller et al., 2003). However even here, disease relapse can occur and we
still do not understand at the fundamental level what balance of cellular
processes drives disease progression. Other associations can be made be-
tween leukaemias and genetic abnormalities: for example, acute leukaemias
with mixed-lineage leukaemia (MLL) fusion genes such as MLL-ENL, MLL-
AF4 and MLL-AF9 (Cozzio et al., 2003; Domer et al., 1993; Krivtsov et al.,
2006; Rubnitz et al., 1994), and acute lymphoblastic leukaemia with hy-
podiploidy (Harrison et al., 2004).
The “cell of origin” question remains a challenging one in the study of
leukaemias: from what healthy haematopoietic cell population did the
leukaemia arise? This question is not the focus of this work and it is raised
here only so that two points can be made. For the purposes of our study,
this question of cancer origin is tangential. We focus on the progression of
disease from some (non-zero) initial malignant population. The moment at
which the cell of origin question becomes relevant to us is when discussing
which haematopoietic species leukaemia cells are competing against – stem,
progenitor or di↵erentiated. Also, note that the term cancer stem cells (see
below) relates to the stemness properties of the cell population and not to
its population of origin (Dick, 2008).
Regarding the driving mechanism of leukaemias, and of cancers more gen-
erally, there are two predominant theories. The first proposed mechanism
is that cancer is driven by clonal evolution (Nowell, 1976), whereby all can-
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cerous cells have tumorigenic potential and any successful cancer treatment
must kill most – if not all – of the a↵ected cells. The alternative proposal is
that a tumour is driven by a subpopulation of cells that have the capacity to
metastasise and form new tumours and that only this subpopulation needs
to be targeted and eradicated in order to cure the disease. This subpop-
ulation ought to exhibit stem-like properties and are referred to as cancer
stem cells. Evidence for cancer stem cells was found about 15 years ago, by
Bonnet & Dick (1997), and others.
According to the cancer stem cell theory, the tumour would have a hierarchi-
cal organisation similar in structure to the healthy haematopoietic system
(as well as other adult-stem cell derived tissues). Some of the early evidence
for such tumour organisation came from studying acute myeloid leukaemia
(Bonnet & Dick, 1997; Lapidot et al., 1994). More recent work has studied
whether stem cells can also be found in other types of leukaemia (Bernt
& Armstrong, 2009; Jamieson et al., 2004; Krivtsov et al., 2006). Despite
growing support for the cancer stem cell theory, evidence is not conclusive
and many questions remain (Dick, 2008; Medema, 2013; Passegue´ et al.,
2003; Wang & Dick, 2005). Much of the evidence used in support of the
theory comes from transplantation experiments in mice, but it has not been
shown that transplanted cancer ‘stem’ cells can indeed recapitulate in full
the heterogeneity of the primary tumour (Shackleton et al., 2009). In the
work that follows, the cancer stem cell theory is adopted. Even if the theory
does not hold for all cancers, its application to leukaemias is well supported
(Reya et al., 2001), and it provides a basis upon which to study the inter-
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actions between healthy and cancerous haematopoietic cells. The reality
of cancer progression is probably a mixture of clonal and stem cell-driven
evolution.
By adopting the cancer stem cell theory, we consider a leukaemia as being
composed of two subpopulations: leukaemia stem cells (LSCs) and non-
stem (di↵erentiated) leukaemia cells. It is assumed that LSCs share certain
properties with their healthy counterparts – haematopoietic stem or pro-
genitor cells. At least, they share the ability to self renew (indefinitely)
and di↵erentiate into a mature – non-proliferative or non-tumorigenic –
cell population. LSCs and HSCs may also respond to many of the same
signals, although given the often aggressive nature of leukaemia growth,
it seems probable that at some stage LSCs no longer respond correctly to
quiescence/cell death signals.
It is commonly assumed that LSCs will be rare within a tumour and make
up only a small fraction of cancer cells (Lane et al. (2009) suggest that
“as few as one in a million” acute myeloid leukaemia cells have leukaemia
initiating potential). However, it has been shown both mathematically
(Johnston et al., 2010) and biologically (Quintana et al., 2008) that LSCs
could comprise any fraction of a tumour. In the subsequent modelling
framework used, this is taken into account by not placing restrictions on the
LSC population size relative to other leukaemia or healthy haematopoietic
populations.
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2.5 Competition within the niche
In Section 2.3 above, the concept of the HSC niche was introduced, followed
by an introduction of leukaemia and cancer stem cell theory in Section 2.4.
Here we bring these topics together and discuss competition with regards
to haematopoiesis.
We study leukaemia as a stem cell disease, driven by LSCs, occurring within
a stem cell niche inside the bone marrow. The assumption that LSCs oc-
cupy the same niche (or similar niches) to HSCs is central to this work.
It has been shown in vivo that leukaemia progression disrupts di↵erent
haematopoietic cell species in di↵erent ways within the niche (Hu et al.,
2009; Miraki-Moud et al., 2013). There is also evidence to suggest that
leukaemia might compete with healthy haematopoietic species by directly
changing the microenvironment to create abnormal niches (Colmone et al.,
2008). Schepers et al. (2013) demonstrate that LSCs can drastically alter
the niche by a↵ecting mesenchymal stem cell and, in turn, osteoblast func-
tion through a number of important signalling pathways. As such, bone
marrow niches may need to be redefined once leukaemia is established.
What remains unknown are the similarities and di↵erences in the ways that
HSCs and LSCs respond to the niche, as well as the extent to which com-
petition is indirect i.e. leukaemia exerts e↵ects mainly on the niche. In
addition, it might be that leukaemic competition exists between LSCs and
haematopoetic progenitor cells (HPCs), leaving the parent HSC popula-
tion not directly a↵ected. This idea is supported by evidence that some
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leukaemias result from HPC populations (Goardon et al., 2011; Passegue´
et al., 2003).
Questions regarding the nature of competition are relevant not just for
leukaemias but also for solid tumours. In other tissues including the brain,
colon and epidermis it has been shown that stem cells can be responsible
for driving the disease (Fuchs et al., 1999; Polakis, 2000; Reya et al., 2001;
Wechsler-Reya & Scott, 2001). In cases where cancers may be clonal (or
non-hierchically organised), there is also competition between the malignant
cells and the healthy cells surrounding them. Given the broad scope of the
modelling undertaken in this work, the conclusions that we draw regard-
ing competition and leukaemia can, in places, inform our understanding of
competition and cancer more generally. There are a number of unanswered
(and crucial) questions in cancer research that relate directly to competi-
tion, such as the poorly understood mechanisms of metastases and how the
competition between healthy and malignant cell species within the body
a↵ects growth and dormancy (Uhr & Pantel, 2011).
In the work that follows, these questions of competition will be addressed
through the development and analysis of models that each target compe-
tition in di↵erent ways. Many of the concepts relating to this competition
between cellular species are taken from ecology; this will be described more
fully in the next chapter. Here, it is su cient to say that the processes gov-
erning both HSCs and LSCs are complex, and yet to be fully elucidated.
Once we combine the two we have an even richer picture that will require
investigation at multiple levels – from molecular to cellular – to successfully
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identify all of their key components.
2.6 Conclusion
Here we have described the biological foundations of this thesis and some
of the most important unanswered questions have been highlighted. At the
heart of this work lies the HSC. An introduction to HSCs has been given,
along with a description of the key regulatory processes governing them
in the microenvironment in which they reside. Additionally, we have in-
troduced leukaemias as haematological malignancies and outlined the ways
that they can interact with the normal (healthy) haematopoietic system.
Given this biological overview, we are now ready to delve into the math-
ematics and theoretical ecology that allow us to describe these biological
processes using models. These models will in turn help us to shed light on
the mechanisms underpinning these biological processes.
Three
Background: theoretical
ecology and mathematical
modelling
3.1 Overview
Mathematical modelling already has a rich history of application to biology,
despite the percieved dichotomy between the mathematical and biological
sciences. Using examples from ecology, we describe how mathematics has
advanced our biological knowledge over the last hundred years. Ecological
examples are particularly relevant here because we base our modelling of
the haematopoietic system on such foundations: we find that ecological con-
cepts provide us with a strong framework upon which to model population
dynamics between cellular species.
20
3.2. Lotka and Volterra: the beginnings of theoretical ecology 21
Subsequently, we present an overview of modelling frameworks appropri-
ate for studying HSCs and leukaemia. The statistical and inferential tools
that we employ are not presented here, but at the appropriate points in
later chapters. Here, to provide background information about the liter-
ature regarding mathematical modelling of HSCs, we first present general
modelling strategies applicable to problems of this type, and then discuss
specific examples of recent models of HSCs and cancer. This allows us to
summarise what has been done so far and what remains to be addressed.
3.2 Lotka and Volterra: the beginnings of
theoretical ecology
One of the best-known models describing a dynamical system is given by
the Lotka-Volterra equations, and owes its name to the work of physicist Al-
fred Lotka and mathematician Vito Volterra (Lotka, 1920; Volterra, 1926).
These equations have been very widely used, and motivate the models that
will be developed later.
The system describes two species, X and Y , interacting in the following
way:
x˙ = x(↵   y) (3.1)
y˙ = y( x   )
where x and y denote the abundances of species X and Y , respectively. In
the absence of Y , X will grow exponentially at rate ↵; in the absence of
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Figure 3.1: The basic Lotka-Volterra equations model two species interacting
through predation. Simulation of the Lotka-Volterra equations as given by
Equation 3.1 with parameters ↵ = 0.3,   = 0.6,   = 0.05. Both species
exhibit oscillations at steady state over some range of values. Time is given
in arbitrary units.
X, Y dies (decays) at rate  . When both species are present, Y consumes
X at rate  xy: proportional to parameter   and the interaction between
X and Y . This system is interesting dynamically because it permits stable
oscillations between X and Y .
Lotka (1920) first proposed these equations and studied them in relation to
the interaction between plants and herbivores. Volterra, unaware of Lotka’s
work, independently devised the same model whilst studying predatory
fishes. Originally published in Italian in 1925, it then appeared in Nature
the following year (Volterra, 1926).
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Hares and lynxes are one of the commonly used examples of species in-
teracting in a Lotka-Volterra type of system. Hares (the prey) would be
species X and lynxes (the predator) species Y in the equations above. As
a simple example, in Figure 3.1, we plot a simulation of Equation 3.1 for
hares and lynxes at a given set of parameter values. It can be seen that both
species exhibit stable oscillations; the stationary state for these parameters
is a limit cycle. From Figure 3.1, we see that the behaviour of lynxes follows
that of the hares: initially lynx growth follows hare growth until the popu-
lation of hares reaches a maximum and begins to decline. Subsequently, the
lynx population peaks and then decreases just behind the hare population
until reaching a minumum value, and the cycle repeats.
There are three important advantages of such an approach that we ought
to take away from the Lotka-Volterra example. The first is that by speci-
fying our biological assumptions precisely using mathematics, we are able
to test them quantitatively in a way that was not possible before. Rather
than suggesting that “growth of a hare population is a↵ected by the rate at
which they are eaten by lynxes” we can quantify this statement by creating
a mathematical model and then test it by simulating the model and study-
ing its ability to describe biological data. Second, we see that this very
simple model with only three parameters already describes quite well the
interactions between two species. Additional terms are needed to provide
a good fit to most real predator-prey datasets, but this most basic model
is a good first step. That (vastly) complicated biological systems can be
described successfully by (very) simple models is perhaps the most impor-
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tant lesson here. Finally, by establishing the validity of this model, we are
able to use it to make predictions and thus prompt new biological hypothe-
ses. For example, we could change the parameter   and study its e↵ect on
the dynamics of the system, mimicking a change in the behaviour of hares
that allows them to better (or less well) evade capture by lynxes. Each of
these points demonstrates the potential of studying biological systems with
mathematical models.
3.3 A century of ecological modelling
Almost sixty years after the work of Lotka and Volterra began, The The-
ory of Island Biogeography was introduced in a book of the same title by
MacArthur & Wilson (1967). Here the authors predicted how ecological
dynamics would determine species’ richness in island habitats; these can
be islands of land surrounded by water, or less traditional ‘islands’ such as
mountain peaks, trees or areas of a lake divided according to their tem-
peratures (MacArthur & Wilson, 1967; Mason et al., 2008). Alternatively,
as we consider in this work, ‘islands’ or niches could be areas within the
bone marrow distinguished spatially or functionally. The theory of island
biogeography took ecology in a new direction. MacArthur & Wilson (1967)
predicted how many species an island could support using a mathematical
formulation (they consider newly created theoretical islands), paving the
way for future decades of niche modelling.
In 1972 and 1973 Robert May published a number of papers in which he
made considerable advances in theoretical ecology (May, 1972, 1973a,b; May
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& MacArthur, 1972). He proved a theorem that told us that as systems (of
randomly interacting species) grow, their stability in general will decrease
and tend towards zeros for large enough (or very highly connected) systems
(May, 1972). This went against scientific opinion at the time, whch stated
that stability ought to increase with complexity (Elton, 1958; MacArthur,
1955). Together with Robert MacArthur, May developed the concept of
niche overlap, showing how variability between species can impact their
ability to occupy the same niche space (May & MacArthur, 1972). One
year later, May published Stability and Complexity in Model Ecosystems in
which these ideas are explained and consolidated (May, 1973b).
A related yet distinct branch of science that was developed alongside the-
oretical ecology is evolutionary game theory. Pioneered by John Maynard
Smith and others, it provided new tools for studying dynamics within pop-
ulations of species: based on a set of players and for each player a set of
strategies, it can be found whether there are evolutionary stable strategies.
These are ones for which, if adopted by the whole (large! infinite) popula-
tion, no mutant can enter and displace the existing species (Maynard Smith,
1982).
There are interesting parallels between the concept of stability as applied to
community interactions in May’s work, and the evolutionary stable strate-
gies of Maynard Smith. They both define conditions under which a system,
if perturbed, will return to its initial state (state before perturbation). Evo-
lutionary game theory provides a di↵erent framework to consider competi-
tion between species, and has been applied to the study of cancer growth
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(Tomlinson & Bodmer, 1997). Such modelling approaches are not presented
in this thesis, but do o↵er interesting avenues for future work.
Recently, there have been extensions to the stability theorem of May (1972)
that move closer towards systems that we might expect to find in the real
world. Allesina & Tang (2012) extended May’s theorem for structured ran-
dom communities of species. That is, interactions between species are still
chosen randomly, but structure is imposed by allowing only certain interac-
tion types, for example predator-prey-type or mutualistic interactions. This
is very interesting work, that moves us closer to ‘real’ biological systems,
however there remains more to be done. The results presented by Allesina
& Tang (2012) still rely on random matrices, thus as models are still a long
way abstracted from the real world. This could be remedied by imposing
further biological structure onto such interaction matrices.
This section has outlined very briefly the important steps in ecological mod-
elling that have been made over the last hundred years. Despite the time
that has passed, questions regarding the stability of ecosystems remain very
topical today, and the debate rumbles on (Evans et al., 2013; Ives & Car-
penter, 2007).
3.4 General strategies for modelling the
haematopoietic system
Many di↵erent quantities can be modelled in biology: gene/protein abun-
dances; gene/protein interactions in simple (e.g. Boolean) networks; abun-
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dances of cellular species; the e↵ects of cytokines, chemicals, drugs or other
interventions on a system or tissue-level e↵ects, to name a few. Here we
are particularly interested in abundances of cellular species. We forsake the
molecular details of the system at hand in order to progress with under-
standing what is happening at the cellular level.
Modelling strategies that are applicable for modelling cellular abundances
can be classified as either deterministic or stochastic; we will discuss each
approach in turn. In this section, strategies are discussed conceptually,
together with a critical review. In the following section a number of concrete
examples are given from the recent literature.
Deterministic approaches describe systems for which, given full details of
the model (parameter values and initial conditions), the time evolution of
the system can be known exactly. This means that if a system is restarted
multiple times from the same initial state it will always return to the same
future states. Ordinary di↵erential equations (ODEs) and partial di↵eren-
tial equations (PDEs) are two examples (Murray, 2008). PDEs are more
flexible than ODEs, but the simulation and analysis of models based on
PDEs quickly becomes computationally very expensive and often unfeasi-
ble. An ODE could be specified by Equation 3.2, where the dynamics of
variable x are controlled by a function F :
dx(t)
dt
= F (x(t)). (3.2)
Equation 3.3 below gives an example of a PDE, where we now have a
variable u(x, t) that is a function of both x and t and whose dynamics are
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controlled by a function G. For example, G = c@
2u
@x2 gives the di↵usion
equation, where c is constant.
@u(x, t)
@t
= G(u(x, t)). (3.3)
Deterministic methods provide good summaries of population-level behaviour:
they are appropriate whenever population sizes are large enough. When
populations become very small, the e↵ects of random fluctuations are im-
portant and stochastic methods are required.
Stochastic approaches, in contrast to deterministic ones, describe systems
for which temporal evolution has unpredictable elements due to the in-
clusion of randomness somewhere in the system. These are popular for
modelling biological systems, since in biology examples of randomness and
heterogeneity abound. Such approaches have yielded many important re-
sults, and ought to be used whenever population sizes are small enough that
fluctuations cannot be ignored. In most cases, population averages will be
recovered from a stochastic model when the abundances grow large enough.
In some cases, where little is known about the system, it is best in the first
instance to investigate with deterministic models to see whether they can
already capture the behaviour that one is attempting to describe. If this is
the case, then the additional complexity of a stochastic model is probably
unnecessary.
A stochastic modelling formulation similar to use of ODEs is provided by
stochastic di↵erential equations (SDEs) (Gardiner, 2009). One way to cre-
ate an SDE model is to take a set of ODEs and to each add a noise term,
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often Gaussian, i.e. add a noise term ⌘ where ⌘ is a random variable dis-
tributed according to ⌘ ⇠ N(0,  2). Such an approach can capture popula-
tion dynamics that exhibit stable fluctuations around some mean value.
Alternatively, one can begin directly from the master equation. This de-
scribes the probabilistic evolution of a state (or set of states) over time. For
example, if the states are discrete then the master equation can be written
as
dP (t)
dt
= P (t)Q (3.4)
where P (t) is a vector of states given at time t and Q defines a matrix of
transition probabilities between the states of the system (Wilkinson, 2011).
An algorithm that was introduced by Gillespie (1977) provides an exact
method for simulating such a system, although it can be computationally
very expensive for large numbers of molecules or over large timescales. In
these circumstances, approximate methods exist to reduce simulation times
such as the ⌧ -leaping algorithm, an extension of the original Gillespie algo-
rithm presented by Gillespie (2001). These methods account for the exact
numbers of molecular/cellular species, rather than their concentrations that
are given by, for example, ODE models.
Agent-based modelling provides a di↵erent strategy, and is usually at-
tempted stochastically, although it can also be performed in a deterministic
framework (Gilbert, 2008; Jost, 2005). Here, individual agents act accord-
ing to a set of rules. For example, from within a population of HSCs, a cell
chosen at random could either self-renew or di↵erentiate, with a probability
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associated with each process. Such a framework considers cells in a very
di↵erent way than do di↵erential equation methods, by treating each as an
autonomous agent and thus studying the population dynamics in a “bottom
up” manner. Di↵erent treatments of temporal evolution are possible: cells
within the system can be updated synchronously or asynchronously (and if
the update is asynchronous, it can also be with or without replacement).
Agent-based approaches may appeal to our intuition – and the evidence –
on HSC behaviour: each cell can act di↵erently and follow distinct paths
that can be seen as the result of a chain of decisions. The main limitation
of this approach is that certain analyses are computationally expensive or
infeasible due to the cost of treating each cell individually. Modelling feed-
back also presents a challenge because the state of the focal cell is dependent
on the current states of other cells.
Cellular automata are a subset of agent-based models that impose spatial
structure on the system by constraining the agents of the system on to
a grid, in two or three dimensions (von Neumann, 1966; Wolfram, 1983).
The agents are then updated according to a set of (deterministic or – more
commonly – stochastic) rules. Each grid point can be occupied by at most
one cell of a certain type (the model can contain multiple cell types). These
rules are functionally similar to the rules a general agent-based model will
follow, but with spatial criteria. For example, in a simple cellular automa-
ton of one cell type where the eight nearest neighbours of a cell on a two
dimensional grid influence its behaviour, a model could obey the following
rule:
3.4. General strategies for modelling the haematopoietic system 31
1. if surrounded by less than four cells, divide, creating a new cell at a
free neighbouring grid point,
2. if surrounded by more than six cells, die
3. else, do nothing.
Cellular automata exhibit spatial relationships between di↵erent cell types
and o↵er the advantage of being easy to interpret biologically. The main
challenges associated with these models are that the update rules may not
translate clearly into biological hypotheses, i.e. it is not clear how we should
interpret the meaning of rules (1) and (2) above. Furthermore, simulation
of cellular automata can be very expensive, as for other agent-based models.
Fitting such models to data is at the limits of what is currently feasible since,
despite great advances in cellular imaging technology, obtaining su cient
resolution of cell dynamics to fit to a model is rare. This is beginning to
change however, and performing parameter inference on spatial models is
an exciting future prospect.
Moving away from agent-based approaches, branching processes present yet
another way to consider the dynamics of cell populations (Haccou et al.,
2007). Here, a population evolves according to how many o↵spring (of one
or more types) each individual produces at each time point (time may be
discrete or continuous). In a simple case, the number of o↵spring produced
by all individuals follows the same probability distribution, however this
assumption can be relaxed allowing for di↵erent types of individual to pro-
duce o↵spring according to di↵erent distributions. Branching processes are
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attractive for their easy interpretation and, for simple models, obtaining an-
alytical results is possible. The main limitations of branching process mod-
els is that they quickly become intractable once di↵erent fates of o↵spring
are considered, or if the progeny are drawn from di↵erent probability distri-
butions. Additionally, the only two equilibria that they o↵er are extinction
or exponential growth. Their lack of ability to reach non-zero steady states
limits their biological plausibility, since although the ultimate fate of any
individual (cell or person) is death, in modelling haematopoiesis we wish
to capture homeostatic mechanisms, not just the eventual extinction of the
system.
This overview of modelling approaches commonly used in systems biology,
and that might be appropriate for problems relating to the haematopoietic
system, is of course not exhaustive, but introduces commonly used methods
that have led to recent advances in understanding HSCs. In the next section,
specific examples of each approach are given, with critical appraisal.
3.5 Modelling haematopoiesis: the state of
the art
Recent models of haematopoiesis and leukaemia are presented here, with
brief discussion of their methods, findings, strengths and limitations. The
models studied in subsequent chapters will build upon and extend these, so
we must begin with a clear understanding of the current methods used to
model HSCs: deterministic, stochastic, and those incorporating a descrip-
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tion of the dynamics of cancer.
3.5.1 Modelling healthy haematopoiesis
ODE modelling accounts for the largest proportion of approaches taken
here. Manesso et al. (2013) present a model containing details for many
species in the haematopoietic hierarchy, and use it to study the system in
cases of homeostasis and under perturbation. This model is appealing for
its coverage of species within the hierarchy (including many stem and pro-
genitor species explicitly), and it was able to recapitulate observed steady
state levels of species within the hierarchy following a perturbation such as
haemorrhage.
Huang et al. (2007) and later Chickarmane et al. (2009) study a particular
mechanism within the hierarchy: the branching point where erythroid and
myeloid lineages separate. A small circuit of two genes (GATA1 and PU.1)
seems to control this process and studying its dynamics using ODEs yields
interesting results about branching cell fates and lineage choice. The au-
thors propose a gene circuit design that permits bistability and find that
this leads to a loss of cooperativity between the two genes and as such
the creation of a “primed” state: an interesting proposed step in cell fate
determination.
Qu & Ortoleva (2008) o↵er another angle on cell fates: they model stem cell
di↵erentiation in an attempt to understand how the asymmetric/symmetric
decision might be made. They model cell fate as being controlled by bio-
chemical reactions occurring within the cell. The model is used to search for
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gene-regulatory circuit motifs that could promote stem cell di↵erentiation.
A mixture of stochastic kinetics and ODEs (as the mean approximation of
the stochastic case) are used by Mangel & Bonsall (2008) to model HSC
processes of self renewal and di↵erentiation. Mangel & Bonsall (2008) use
results from life history theory to describe conditions for which HSCs can
survive for longest in the niche. In later work, using similar strategies, the
same authors argue that stem cell biology ought to be considered in the
light of population biology and in terms of the demands an organism makes
on the HSC system (Mangel & Bonsall, 2013).
Schittler et al. (2012) study HSC proliferation and di↵erentiation using
a structured population model and a mixture of ODEs and PDEs. This
model is interesting because it can capture di↵erent proliferation properties
in di↵erent cell subpopulations.
Delay di↵erential equations have also been used to study haematopoiesis.
Such equations exhibit interesting dynamics with periodic or chaotic solu-
tions, depending on parameter values. Mackey & Glass (1977) present delay
di↵erential equations with which they suggest that they can recapitulate the
behaviour of periodic fluctuations in di↵erent blood cell populations.
Xu & Xu (2010) use a di↵erence equation approach to address questions of
HSC di↵erentiation. They study the stability of their model and from their
analysis derive conditions that allow for oscillatory behaviour of HSCs.
In addition to the (mostly) deterministic methods used above to study the
healthy haematopoietic system, a number of recent stochastic models de-
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scribe di↵erent properties of healthy haematopoiesis. As introduced above,
branching processes describe the dynamics of a population by the number of
o↵spring each member has at each time point, and are thus naturally suited
to the study of cell division. Alexandersson (2000) has studied branching
process models of cell fate, aimed specifically at the cell cycle, but which
could also be used to model HSC fate. Also using branching processes, Nor-
don et al. (2011) describe the inheritance of generation times from mother
to daughter cells and show that it is possible to describe both single cell
and multi-cell systems with such methods.
Marr et al. (2012) use branching processes and – in addition – present a
stochastic toggle switch model to describe the granulocyte-monocyte branch-
ing point in the haematopoietic hierarchy. They find that the di↵erentiation
probability of a granulocyte-monocyte progenitor cell can be inferred using
a branching process model but the branching process model cannot capture
time dependence of this probability that the data suggest. They do manage
to describe this time dependence with their stochastic toggle switch model,
and in fitting their model they see a separation of timescales in the rates
governing branching cell fates; one happens on a faster timescale than the
other.
The GATA1 – PU.1 gene switch that was considered above from an ODE
perspective has also been analysed stochastically, via construction of a
Boolean network in order to elucidate di↵erent attractors of the system
(Krumsiek et al., 2011). Using this method, the authors claim to describe
successfully the four di↵erent cell fates considered according to gene expres-
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sion profiles.
Villani et al. (2011), in an approach similar to Krumsiek et al. (2011),
present an interesting model that describes cell di↵erentiation as an emer-
gent property of the underlying gene transcriptional network. They do this
using random Boolean networks and link network attractors to di↵erent
cell fates. They use this model to stress the role that noise has in driving
di↵erentiation.
The above work represents current approaches to modelling the
haematopoietic system unperturbed by disease. Many insights have re-
cently emerged from such approaches, for example regarding cell fate de-
termination and mechanisms for homeostasis. We now proceed to examine
models of haematopoiesis in the presence of disease.
3.5.2 Modelling malignant haematopoiesis and
cancer
The work presented here describes recent attempts to use models to predict
the behaviour of HSCs when leukaemia is present in the system, alongside a
few models of non-haematological cancers, introduced here for the purposes
of studying cancer stem cell dynamics.
Roeder & Loe✏er (2002) develop an agent-based model to describe the
stem cell dynamics of self renewal and di↵erentiation and from this work
and its extensions (Horn et al., 2013; Roeder et al., 2006, 2005) the model
demonstrates the ability to reproduce expected stem cell behaviours both
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in health and when under competition from malignant HSCs. In appli-
cation to predicting system behaviour in the presence of chronic myeloid
leukaemia (CML), the authors suggest that the e cacy of drug therapy
can be increased by stimulating proliferation during therapy (Roeder et al.,
2006). They also provide a predictor for the chance that an individual pa-
tient will relapse, thus o↵ering the potential for patients who are predicted
not to relapse to be taken o↵ treatment after some time (Horn et al., 2013).
In 2005, Michor presented a di↵erent model for CML, using ODEs. This
model was used to suggest that leukemia progresses by a biphasic decline
(under treatment), with the first phase representing death of di↵erentiated
leukaemia cells and the second representing death of leukaemia progenitor
cells. This model was one of the first descriptions of CML dynamics and
provides interesting results, but it does not take into account interactions
between healthy and CML lineages (Michor et al., 2005).
Extensions to this model added interactions between HSCs and LSCs, and
these new versions were used to model CML dynamics and attempt to
provide better treatment practice. The authors predict that adding a stem
cell stimulating factor does not enhance treatment of CML (Foo et al., 2009)
and suggest that it might not be safe to discontinue treatment even when
disease reaches very low levels (Tang et al., 2012).
Colijn & Mackey (2005) present a model of periodic chronic myeloid
leukaemia that incorporates the dynamics of both di↵erentiated
haematopoietic populations (erythrocytes, leukocytes and platelets) and
HSCs to describe the dynamics of this periodic type of CML. They use dif-
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ferential delay equations to model the system and find that certain parame-
ters are particularly important to simulate disease dynamics that accurately
reflect patient data.
Moore & Li (2004) present another dynamical model of CML that studies
the disease from a di↵erent angle, examining the interactions between CML
cells and T cells. They use ODEs to model the system and latin Hypercube
sampling to cover the parameter space of interest, and find that param-
eters controlling CML growth and death rates are the most important in
determining outcome of the system (level of CML).
Traulsen et al. (2012) look at how disease in the haematopoietic system can
arise from a neutral mutation (rather than one that confers a selective ad-
vantage to its progeny) using a Moran process (a type of branching process
used to describe genetic drift). They suggest that leukaemias that arise due
to a neutral rather than selective process may be harder to treat.
La Porta et al. (2012) use another branching process model, here to study
senescence in tumours. Their results suggest that inducing senescence in
cancer cells is a poor treatment strategy for most tumours, and instead
that e↵ort should be focused on eradicating cancer stem cells – cells that
are likely resistant to senescence.
Enderling et al. (2009) present a cellular automaton model that studies tu-
mour growth. This approach is a good example of what can be achieved
using cellular automata, it manages to link update rules to biological pro-
cesses quite well and produces some fascinating results. Most important is
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the finding that tumour suppression – via increasing the tumour cell death
rate – can increase the long term growth rate of the tumour by o↵ering free
space to cancer stem cells in which they can proliferate. If this paradoxical
result does indeed match the biology of tumours, it has strong implications
for cancer therapy.
Alarco´n et al. (2003) also use cellular automata to study tumours. They
are particularly interested in angiogenesis and its impact on cancer growth.
They demonstrate that their cellular automaton model can simulate the
e↵ects of blood flow and red blood cell heterogeneity. This model is in-
teresting and somewhat more sophisticated than that of (Enderling et al.,
2009), although (perhaps to compensate) it is simulated on a much smaller
grid. The authors suggest that blood flow heterogeneity has a strong influ-
ence on tumour growth and can limit it considerably.
Daukste et al. (2009) model tumour dynamics from another perspective:
placing cell cycle times at the centre of their analysis. They assume that two
subpopulations exist within a tumour (stem and non stem cells) with two
di↵erent characteristic cycling times. They model these populations with
ODEs and compare the model to data that describe cell cycle dynamics of
tumour cell lines in culture.
Zhu et al. (2011) also study tumour growth using ODEs under the as-
sumption of the cancer stem cell model. They include a description of the
stem cell niche in this model, and additionally model the impact of the
epidermal growth factor signalling pathway on tumour dynamics. Their
main findings propose important roles for niche size and over-expression of
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epidermal growth factor receptor in tumour progression.
These examples from literature are chosen for interest and relevance and the
list is of course far from being exhaustive. The above models have advanced
our knowledge of the dynamics and e↵ects of leukaemia, helping to elucidate
the role of interactions between di↵erent types of healthy and cancer cells,
proposing new hypotheses and suggesting new routes for experimentation.
Despite such advances, many fundamental questions remain regarding dis-
ease incidence and – of greatest interest here – how interactions between
haematopoietic cells, leukaemia and the niche a↵ect disease progression.
3.6 Conclusion
In this chapter we discussed how the haematopoietic system has been
treated mathematically, both in a historical context and through a number
of current examples. There is a rich history of interplay between ecol-
ogy and mathematical modelling, each benefitting the other. This history
places current approaches in context, and introduces many of the concepts
that remain pertinent today, especially that of competition between cellu-
lar species. We presented an overview of modelling approaches applicable
to the haematopoietic system in health and disease, and went on to give
a number of examples from the literature, covering both deterministic and
stochastic approaches. This provides a platform from which we will develop
new methods in an attempt to understand in greater depth the haematopoi-
etic system.
Four
A new framework for stability
analysis and its application to
stem cell niche models
4.1 Overview
Linear stability analysis is a useful tool for the analysis of nonlinear dy-
namical systems, and important results have arisen from its application
to studying the behaviour of ecosystems. In this chapter we extend these
methods and apply them to stem cell (eco)systems. We consider the sta-
bility properties of the fixed points of a system, not for a single parameter
vector, but for many values, sampled over the parameter space. This gives
us the probability that a fixed point is stable, over some range of param-
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eters. We can use this framework also to investigate other properties of a
model’s fixed points, such as their ‘basins of attraction’ in parameter space.
We apply these methods to a model from the literature to illustrate their
use and we show from this example that dependencies and heterogeneity
in biological systems dramatically change the stability properties of their
fixed points. Subsequently, we focus our attention on models of stem cell
niche dynamics and study the properties of their fixed points. We find that
in most cases the fixed points are always stable when they are reachable
from a certain point in parameter space. When models have multiple fixed
points with biologically interesting properties (all species should be posi-
tive finite), we study what parameter values permit each and from this we
can learn about the behaviour of the model. This probabilistic framework
provides new methods for the analysis of the fixed points of a model and
gives insight into how stability can be achieved, especially in the case of
stem cell niche models.
4.2 Introduction
4.2.1 Motivation
Many mathematical models describing biological (and other) phenomena
are constructed using ordinary di↵erential equations (ODEs). The be-
haviour of an ODE system can be categorised into two classes: transient
and steady state behaviour. The latter describes the system over large
timescales (time ! 1). For those systems that reach single valued (i.e.
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not oscillating) steady states, we refer to values that system variables take
at steady state as the fixed point of the system (Glendinning, 1994).
Given an ODE system that has one or more fixed points, it is interesting
to ask: what happens to the system following a small perturbation in some
direction away from the fixed point? There exists a well-established frame-
work for such investigation known as linear stability analysis (Strogatz,
1994). According to this definition, a model’s fixed point is called stable if,
subsequent to perturbation from that fixed point, the model returns to the
same place.
We are particularly interested in the application that this type of stabil-
ity analysis has found in studying ecological systems. Here, it has been
combined with concepts from random matrix theory to study the stability
properties of ecosystems, as pioneered by Gardner & Ashby (1970) and May
(1972). However, in order to be able to derive analytical results, these meth-
ods have only considered species whose interactions are drawn from random
matrix distributions that dictate that entries be independent and identically
distributed (i.i.d. ). This situation is far away from what we expect to see
in nature, where correlations and dependencies abound (Kokkoris et al.,
2002). To remedy this we need to look at models of biological systems that
account for such dependencies. We look at ODE examples of biological sys-
tems and use Monte Carlo methods to analyse their fixed point behaviour,
since in these cases we cannot derive results analytically.
Our goal is to gain insight into the probabilistic stability properties of real-
world systems, where previous analyses have only tackled highly idealised
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i.i.d. versions of these. In the next section an overview of linear stability
analysis is presented, with a description of its applications in ecological
modelling.
4.2.2 Background on linear stability analysis
We begin with some definitions. A system is a set of interacting dynamic
variables. Since here we are considering systems such as those found in
an ecological setting, we refer to the variables as species. We consider
(eco)systems whose dynamics can be described by ODEs, so we can write
down the system dynamics in general form as
x˙(t) = F(x(t)) (4.1)
where x(t) is a vector of size n (n is the total number of species) that gives
the abundance of each species at time t (we will use x(t) = x i.e. time
dependence implicit). The abundance could be represented by whole num-
bers of species or by their concentration, given by the fraction of a species
occupying a certain space. F(x(t)) = [F1(x(t)), F2(x(t)), ..., Fn(x(t))] are
non-linear functions that define the rates of change of the species and in-
clude the model’s parameter dependencies.
Since we are interested in the behaviour of the model close to steady state,
we consider a Taylor expansion of F (x(t)) about the point x0, where x0
defines a fixed point of the system. In doing so we aim to learn about how
the model responds to perturbations from this steady state. Discarding
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terms of order x2 or higher from a Taylor expansion we have
x˙ = F (x0) + (x  x0)@F (x0)
@x
. (4.2)
Since x0 is a fixed point of the system, F (x0) = 0. Substituting y = x x0
we have the linearised system
y˙ =
@F (x0)
@x
y ⌘ Ay (4.3)
where A is called the Jacobian matrix in a mathematical context or the
community matrix in an ecological one (Levins, 1968). We can study A to
determine properties of the system at hand. Specifically, we can find the
eigenvalues of A ( i where i 2 (1, 2, ..., n)) by solving
det(A   I) = 0 (4.4)
for  , where I is the n ⇥ n identity matrix. We can then use the   to
define stability criteria: if Re{ i} < 0 8i then the system is stable about
the point x0: if the system is perturbed slightly from state x0, it will return
to the same state following some time delay. If this condition does not hold,
the fixed point is unstable. See, for example, Strogatz (1994) for further
discussion of linear stability analysis. This definition of stability is used
in a broad variety of applications in dynamical systems; we are interested
particularly in its ecological applications, by May (1973b) and others.
Forty two years ago, Robert May proved a theorem that demonstrated that
as the complexity of a system increases, its stability will in general decrease
and for large enough systems tends towards zero (May, 1972). Complexity
here is quantified either by the total number of species in the system or by
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the number of links between them. For a randomly connected system of n
species, with connectance — the number of actual links over the number of
all possible links — C and average link strength (or variance) ↵, then, for
large n, a system will almost certainly be stable when
↵ <
1p
nC
(4.5)
(May, 1972). This result contradicted current opinion of the time which
stated that in general as systems grow in complexity their stability should
increase (Elton, 1958; MacArthur, 1955). The implications and uses of
this theorem have been wide and varied; outside of ecology it has found
application in fields including molecular biology and economics.
Given this theorem, a question arises, namely, how do large systems persist
in nature? As their size and complexity increases, Equation 4.5 states that
their probability of stability will eventually approach zero. To begin to
answer this, note that Equation 4.5 gives a statement about the behaviour
of systems where links between species are placed at random. Of course
in the real world interactions are not completely random but guided by
evolution. This imposition of structure upon a system can increase its
stability: the relationship between structure and stability will be explored
further in this chapter.
Results regarding the stability of biological systems by May, and recent
extensions to his work by Allesina & Tang (2012), rely on interactions
between species being i.i.d. because they appeal to a theorem known as
the circular law, and its extensions (Girko, 1984; Tao et al., 2010). This
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Figure 4.1: Illustration of the circular law for a random matrix distribu-
tion. Jacobian entries for 5⇥ 5 matrices are drawn from an empirical i.i.d.
distribution. The eigenvalues for each Jacobian are calculated and can be
plotted on the complex plane, as shown here.
states that, given a system of n species with interactions between them
drawn according to an i.i.d. distribution, then in the limit n ! 1, the
eigenvalues of the system lie on a circle in the complex plane. In the case of
finite n, the spectral distribution of eigenvalues still approaches a circular
distribution, with some “bleeding” at the edges, especially along the real
axis. As an example, shown in Figure 4.1 are the eigenvalues of 100,000
5⇥ 5 matrices with i.i.d. entries. In this chapter we use the circular law as
a point of comparison with our numerical results.
4.2.3 Extending linear stability analysis
In the remainder of this chapter we will apply these concepts of stabil-
ity and extend preexisting methods for the analysis of complex systems.
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These extensions allow us to study the stability properties of ‘real’ biologi-
cal systems where previously only i.i.d. systems have been studied. In the
case of Allesina & Tang (2012), structure was imposed, for example in the
form of predator-prey-type interactions or mutualistic interactions, but the
sampling distributions used were still i.i.d.
We start with the assumption that stem cell species and their progeny act
similarly to animal species in ecology: we are interested in learning about
the behaviour of stem cell systems near to their fixed points. We seek to
discover how the systems respond following perturbations.
The stem cell models used for analysis are introduced and described in
the next section. Subsequently in section 4.4 we will present the methods
that we have developed for generalised stability analysis. In section 4.5.1
we present results using this method for a general system — a version
of the Lorenz model, and then, in sections 4.5.2 - 4.5.3 we analyse stem
cell niche models via this framework. This analysis reveals how system
structures, more than dependencies, maintain overall stability. By studying
those systems that permit multiple biologically relevant steady states, we
make predictions about cell lineage choices in a stem cell hierarchy. We end
with discussion and some conclusions.
4.3 Model development
We develop 10 di↵erent ODE models that describe stem cell di↵erentiation
dynamics. They all share common features and di↵er in those parts that
4.3. Model development 49
we wish to compare and contrast. In each model we have a three-layer hi-
erarchy, consisting of stem, progenitor and di↵erentiated cells. Each model
is built from a set of shared rules that describe cellular growth, death and
di↵erentiation. These rules also define how one species can regulate the
growth of another through feedback.
The models di↵er in the number of species that exert and experience the
e↵ects of feedback. They also di↵er in the total number of species: models
S1 - S4 each have three species and models S5 - S10 each have five. In S5
- S10, the extra two species result from a branching point that represents
branching cell fates: when the stem cell divides it is able to di↵erentiate
into one of two progenitor species, each of which produces di↵erentiated
cell progeny. Such branching points occur frequently in the haematopoietic
hierarchy, such as the myeloid/lymphoid branching (from a multipotent
progenitor cell) or the monocyte/granulocyte branching from a granulocyte
monocyte progenitor (see Figure 2.1).
All of the S-models share a common set of assumptions. Namely, that
• stem and progenitor cells can self renew, but di↵erentiated cells cannot
• di↵erentiation is irreversible (dedi↵erentiation is not allowed)
• stem and progenitor species cannot die or migrate out of the niche
• feedback enters the model through linear growth inhibition of one
species on either itself or its parents/grandparents.
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The models are parameterised by terms representing growth, di↵erentiation
and death rates. We are going to investigate the region of parameter space
p 2 [0, 1] for each model parameter p. Parameters are assigned biological
meaning, thus should never be negative, and we set the upper limit to be
1 so that each p is interpreted as a rate parameter. This limit can be set
without loss of generality: di↵erent parameter ranges could be studied with
a rescaling parameter that would not alter the results beyond a rescaling of
time (here given in arbitrary units).
4.3.1 Models S1-S4: three-species models
Model S1: This model describes the dynamics of the following species in
the haematopoietic hierarchy: HSCs (x0), progenitor cells (x1) and di↵er-
entiated cells (x2). Their dynamics are given by
x˙0 = ax0(1  x0   x1   x2)  bx0 (4.6)
x˙1 = bx0 + cx1(1  x0   x1   x2)  ex1
x˙2 = ex1   gx2
where the parameters (a, b, c, e, g) characterise the phenotypes of the species
and are described in Table 4.1. See Figure 4.2 for graphical representation
of model S1. Here, populations x0 and x1 self-renew at rates a and c,
respectively. They di↵erentiate into daughter species at rates b and e, re-
spectively, and x2 dies/migrates out of the niche at rate g. There is also
feedback onto the self renewal terms of x0 and x1: these are a↵ected by all
species in the model.
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Model S2: The only change made here compared with S1 above is in
the feedback: now x2 does not inhibit stem and progenitor cell populations.
The equations describing S2 are
x˙0 = ax0(1  x0   x1)  bx0 (4.7)
x˙1 = bx0 + cx1(1  x0   x1)  ex1
x˙2 = ex1   gx2
where the same parameter set characterises the model; the model is shown
in 4.2.
Model S3: This model simplifies the three-species lineage further, remov-
ing another layer of feedback and leaving only saturating feedback from x0
onto itself; x˙1 and x˙2 are now given by linear expressions. Model S3 is
governed by
x˙0 = ax0(1  x0)  bx0 (4.8)
x˙1 = bx0   ex1
x˙2 = ex1   gx2
where the parameters (a, b, e, g) have the same meaning as above, described
in Table 4.1.
Model S4: In the final three-species model we investigate the e↵ects of
keeping regulation of the stem cell pool but removing it from the progenitor
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Symbol Definition
a Rate of self renewal of x0
b Rate of di↵erentiation of x0 ! x1
c Rate of self renewal of x1
e Rate of di↵erentiation of x1 ! x2
g Rate of death of x2
Table 4.1: Description of parameters that characterise models S1-S4.
cell population. The equations governing S4 are
x˙0 = ax0(1  x0   x1)  bx0 (4.9)
x˙1 = bx0 + cx1   ex1
x˙2 = ex1   gx2
where the same parameter set characterises the model as for S1 and S2 and
the model is shown in Figure 4.2.
By comparison of the fixed points of models S1-S4 we aim to discover how
more or less feedback impacts upon their stability.
4.3.2 Models S5-S10: five-species models
In the second set of models of this family, we include two more species.
HSCs are still denoted x0 and we now have two progenitor cell populations,
x1 and x2, that di↵erentiate into two di↵erentiated cell populations, x3 and
x4, respectively.
4.3. Model development 53
P"
D"
S1# S2#
S"
P"
D"
S"
S3# S4#
P"
D"
S"
P"
D"
S"
Figure 4.2: Graphical depiction of models S1-S4. The three cell species in
the hierarchy are stem, progenitor and di↵erentiated cells. Black arrows
denote self renewal and di↵erentiation processes and red arrows denote in-
hibitory feedback processes. S2 and S4 are subtly di↵erent: note the double
arrowhead.
Model S5: This model contains feedback only onto x0 from progenitor
cells, and its equations are
x˙0 = ax0(1  x0   x1   x2)  (c1 + c2)x0 (4.10)
x˙1 = c1x0   e1x1
x˙2 = c2x0   e2x2
x˙3 = e1x1   g1x3
x˙4 = e2x2   g2x4
where (a, c1, c2, e1, e2, g1, g2) characterise the model. A graphical depiction
of S5 is given in Figure 4.5.2, alongside depictions of the models S6 - S10
that are introduced below. The parameters that specify this model are
given in Table 4.2.
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Model S6: This model extends S5 by including a separate level of feed-
back: from di↵erentiated cells onto progenitor cells, in addition to the feed-
back exhibited by S5. The equations for S6 are given by
x˙0 = ax0(1  x0   x1   x2)  (c1 + c2)x0 (4.11)
x˙1 = c1x0(1  x1   x3)  e1x1
x˙2 = c2x0(1  x2   x4)  e2x2
x˙3 = e1x1   g1x3
x˙4 = e2x2   g2x4
where the same parameter set as for S5 describes the model.
Model S7: Here we remove the feedback onto stem cells and only con-
sider feedback from di↵erentiated cells onto their parent population. The
equations that specify this model are
x˙0 = ax0(1  x0)  (c1 + c2)x0 (4.12)
x˙1 = c1x0(1  x1   x3)  e1x1
x˙2 = c2x0(1  x2   x4)  e2x2
x˙3 = e1x1   g1x3
x˙4 = e2x2   g2x4
where the parameters are the same as before.
Model S8: This model combines all of the feedback e↵ects we have con-
sidered in S5-S7. That is, we consider the joint e↵ects of (di↵erentiated
! progenitor cell) feedback and (progenitor ! stem cell) feedback. The
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equations that specify S8 are
x˙0 = ax0(1  x0   x1   x2   x3   x4)  (c1 + c2)x0 (4.13)
x˙1 = c1x0(1  x1   x3)  e1x1
x˙2 = c2x0(1  x2   x4)  e2x2
x˙3 = e1x1   g1x3
x˙4 = e2x2   g2x4
where the parameters are the same as before. In the final two models
that we consider, additional parameters are added to model the e↵ects of
progenitor cell expansion.
Model S9: This model shares features with S6, but with the addition of
progenitor cell self renewal. The equations for S9 are
x˙0 = ax0(1  x0   x1   x2)  (c1 + c2)x0 (4.14)
x˙1 = c1x0 + p1x1(1  x1   x3)  e1x1
x˙2 = c2x0 + p2x2(1  x2   x4)  e2x2
x˙3 = e1x1   g1x3
x˙4 = e2x2   g2x4
where (a, b, c1, c2, p1, p2, e1, e2, g1, g2) characterise the model: the pi control
self renewal of the progenitor cells.
Model S10: This model allows for progenitor cell expansion that is un-
regulated either by self or di↵erentiated cells. It provides a bridge between
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Symbol Definition
a Rate of self renewal of x0
c1/2 Rate of di↵erentiation of x0 ! x1/2
e1 Rate of di↵erentiation of x1 ! x3
e2 Rate of di↵erentiation of x2 ! x4
g1 Rate of death of x3
g2 Rate of death of x4
p1/2 Rate of self renewal of x1/2
Table 4.2: Description of parameters that characterise models S5-S10.
models S5 and S9. The dynamics of S10 are given by
x˙0 = ax0(1  x0   x1   x2)  (c1 + c2)x0 (4.15)
x˙1 = c1x0 + p1x1   e1x1
x˙2 = c2x0 + p2x2   e2x2
x˙3 = e1x1   g1x3
x˙4 = e2x2   g2x4
where the parameters are the same as for S9.
This completes the S-model family that will be investigated in this chap-
ter. Before we study the properties of these models in detail, we introduce
our method for stability analysis and give some general results using this
method.
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4.4 Methods
4.4.1 A generalised stability analysis approach
In order to conduct stability analyses for each of the models we evaluate the
Jacobian matrix at each fixed point for a given parameter vector. We sample
the parameter space randomly, keeping only those points that give rise to
fixed points in the positive quadrant, i.e. we discard parameters giving
rise to fixed points that are not feasible in the sense of being biologically
relevant or ‘reachable’, from some initial conditions.
We follow these steps to determine the stability probability for a given
model around a fixed point:
1. Solve x˙ = 0 to find symbolic expressions for the values of each species
(total number n) at each fixed point in terms of the parameters.
2. Sample a 1⇥d parameter vector p (model contains d free parameters)
and evaluate the fixed point for these values. Check reachability: if
the fixed point lies within the positive orthant, i.e. all species   0,
proceed. If not, resample.
3. For p, find the eigenvalues  i, i 2 (1, 2, ..., n) of the Jacobian, J .
Recall that J = @F (x0)@x where F is given by the model equations,
x˙ = F (x) and evaluated at fixed point x0.
4. Repeat steps (2) and (3) until a total of N reachable points are found.
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5. Construct s, where sj = 1 if max(Re{ i}) < 0 for  i of pj 2 p, and
sj = 0 otherwise. i.e. sj indicates whether or not the model is stable
around the fixed point for pj.
6. Calculate the stability probability: P (stable) = 1N
NP
k=1
sk.
Note that the stability probability P (stable) = P (stable|reachable). That
is, we calculate the probability that a given fixed point is stable given
that it is reachable from the starting point (parameter values and initial
conditions).
Aside from calculating P (stable), given the distribution of Jacobian matri-
ces that this analysis gives us, we can also investigate the fixed points of
a model in other ways, such as by quantifying the basins of attraction of
a model and looking at their intersection. We can also look at basins of
attraction in parameter space: the e↵ects that varying parameters (rather
than initial conditions) have on the reachability of the fixed points.
4.4.2 Null distributions to describe the stability of a
model
In this chapter, we set out to study the stability properties of stem cell
models and in particular to determine which properties of the models confer
to them more or less stability around a certain fixed point. So, in addition to
comparison between models, for a single model we would like to compare its
stability properties with those of a permuted version of the same model. In
4.4. Methods 59
doing so we essentially create a null distribution for the stability properties
of a model around a given fixed point.
In fact, we consider two null distributions for each model. First, we sample
with replacement from the empirical distributions that we have for each
entry in the model Jacobian, maintaining the entry place in the matrix –
denote this distribution  i,j. For example, to sample from  1,1 is to sample
from the N values we have for the first entry in the Jacobian: J1,1. This
we call the independent null distribution: it removes dependencies between
entries in the Jacobian. Second, we sample again from the distribution over
all Jacobian entries but now we combine the values for all entries so that,
for each entry in our new Jacobian, we sample with replacement from the
empirical distribution containing the n ⇥ n ⇥ N values – we denote this
distribution ✓. This is an empirical i.i.d. distribution since we are now
sampling independently from the same distribution for each entry in the
Jacobian.
To construct these two null distributions we follow steps (1)-(6) as above
but replace (3) by (for the independent null distribution – ‘independent’
case in Figure 4.3):
• Construct a new Jacobian by sampling with replacement from  (i, j)
for each entry J(i, j) and find its eigenvalues
and (for the i.i.d. null distribution – ‘i.i.d.’ case in Figure 4.3):
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• Construct a new Jacobian by sampling with replacement from ✓ for
each entry in J and find its eigenvalues.
Shown in Figure 4.3 are histograms and pairwise density plots for Jacobian
entries corresponding to the model introduced by Lorenz (1963), which is
described below. We see that the true distributions (those drawn from the
unperturbed Jacobians of the ODE model) are di↵erent for di↵erent entries
– not identical – and that they are not independently distributed, since a
clear correlation is seen for the plotted entry pair, (3, 2) and (3, 3). In the
independent case (introduced above), dependencies are lost although the
distributions are still non-identical. Finally in the i.i.d. case, the distribu-
tions are now identical in addition to being independent.
4.5 Results
4.5.1 Generalised stability analysis enables global
characterisation of the stability of a model and
its fixed points
In order to demonstrate the method of probabilistic stability analysis, we
first consider the model of Lorenz (1963), as an example of a system of
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Figure 4.3: True, independent and i.i.d. distributions over Jacobians of
the Lorenz model. Histograms for each entry in the 3 ⇥ 3 Jacobian for
the Lorenz model are shown, for 100,000 randomly sampled parameters.
Entries are marked and counted from top left. Histograms are shown for
each of the true case, independent case and i.i.d. case (see text for how
these were constructed). For one pair of entries – (3,2) and (3,3) – we plot
the pairwise density using a heatmap, showing that only in the true case
are there dependencies between entries.
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interacting variables. This model is given by the equations
x˙0 =   x0 +  x1 (4.16)
x˙1 = ⇢x0   x1   x0x2
x˙2 = x0x1   bx2
where the parameter set ( , ⇢, b) specifies the model. The model has two
fixed points, one of which is the origin. We perform our analysis on the
other non-zero fixed point. As described in the Methods section, we per-
form stability analysis by sampling 100,000 parameter sets and calculating
the eigenvalues of the Jacobian and thus the stability for each. We also
construct the two null distributions that we use for comparison: the inde-
pendent and the i.i.d. distributions. In Figure 4.4 are the eigenvalue spectra
plotted for these three distributions, both overlaid and as heat maps, where
the density can be seen.
For the true distribution we find the fixed point has a probability of sta-
bility of 0.999: the fixed point is almost always stable from anywhere in
the sampled region of parameter space. The corresponding probability of
stability for the independent case is 0.841 and for the i.i.d. case is 0.105. So
the probability drops in the independent case in comparison with the true
case, but not by a large amount; under this distribution the fixed point is
still stable for the majority of parameters. In the i.i.d. case however, the
fixed point is stable only around 10% of the time.
Looking at the spectra in Figure 4.4 we see that the true and independent
eigenvalue distributions are neither circular nor uniformly distributed. This
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Figure 4.4: Eigenvalue spectra of the Lorenz model under three random
matrix distributions. On the left is a scatter plot showing (left to right)
the i.i.d., independent and true distributions for the Lorenz model. on
the right the same eigenvalue distributions are plotted using a heatmap,
demonstrating that not only are the true and independent distributions
non-circular, but that they are also non-uniform. Eigenvalues with real
part = 0 are omitted from this plot.
highlights the fact that investigating the stability of Jacobian matrices de-
rived from an underlying model rather than a purely random distribution
requires methods other than the circular law.
4.5.2 Structure maintains stability across all
S-models
We now move on to study the fixed points of the stem cell models introduced
above, using the framework we have developed here. In Figure 4.5 we
show an example of the eigenvalue spectra of a fixed point for model S5,
for the three distributions – true, independent and i.i.d. This illustrates
how the true and independent distributions deviate from the circular i.i.d.
distribution, as we also saw above for the Lorenz model.
In order to compare the fixed points for each stem cell model, we calculate
the probabilities of stability for each; these are shown in Table 4.3. We
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Figure 4.5: True, independent and i.i.d. distributions of eigenvalues derived
from model S5. In yellow is the i.i.d. distribution and in orange and red
are the independent and true distributions, respectively. While the i.i.d.
distribution is close to circular, the other two distributions deviate consid-
erably from a circle on the complex plane, illustrating that the circular law
does not hold here.
also give in Figure 4.5.2 the eigenvalue spectra for certain fixed points of
models S5 - S10, alongside the structure of these models. The S5 spectra
shown here di↵er from that shown in Figure 4.5 because Figure 4.5 did not
take into account whether a given fixed point was feasible or reachable, i.e.
the system can reach it from some starting parameter values. Since the
reachability of a fixed point is important biologically, we proceed to analyse
parameter distributions that give rise to reachable fixed points, such as
those shown in Figure 4.5.2.
4.5. Results 65
Model Fixed point True Independent i.i.d.
S1 1 0.25 0.25 0.034
2 0.75 0.75 0.13
3 1.0 0.94 0.19
S2 1 0.25 0.25 0.034
2 0.75 0.75 0.084
3 1.0 0.97 0.14
S3 1 0.50 0.50 0.056
2 1.0 1.0 0.080
S4 1 0.25 0.25 0.034
2 1.0 1.0 0.080
S5 1 0.83 0.83 0.0039
2 1.00 1.0 0.010
S6 1 0.83 0.83 0.0038
2 – – –
3 1.0 1.0 0.018
4 1.0 1.0 0.018
S7 1 0.83 0.83 0.0038
2 1.0 1.0 0.011
S8 1 0.83 0.83 0.0036
2 – – –
3 1.0 0.96 0.023
4 1.0 0.96 0.023
S9 1 0.96 0.96 0.011
2 0.46 0.46 0.0056
3 0.0 0.0 0.0040
4 0.96 0.96 0.011
S10 1 0.27 0.21 0.0021
2 1.0 1.0 0.0
Table 4.3: The stability probabilities for models S1-S10. For each model,
the true stability probability of each fixed point is given, alongside the
associated independent and i.i.d. probabilities. Where probabilities are
not given, this fixed point was not reachable for any parameter values.
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Figure 4.6: Graphical representation and eigenvalue spectra of models S5-
S9. The left hand columns shows graphical representations of the models:
S, stem cell; P, progenitor cell; D, di↵erentiated cell. Black arrows show
self renewal/production processes and red arrows show inhibition processes
(self inhibition is not shown). Shown right are the eigenvalue spectra of
certain fixed points of the models plotted on the complex plane. In purple
is the real spectra, in dark blue the independent spectra and in light blue
the i.i.d. spectra. The fraction of points with negative real part (to the left
of the ordinate) represent the probability of stability for this fixed point.
Not all fixed points of each model are shown. Note that from these repre-
sentations one cannot necessarily extract the probability of stability since
all eigenvalues for each fixed point are shown, not just the largest one.
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In Table 4.3 we have the probabilities of stability for the fixed points of
each model. Fixed point 1 is the origin in each case, the probabilities of
which we are not particularly interested in biologically, so will not analyse
them further here. Fixed point 2 of models S6 and S8 is not reachable for
any parameter values in the sampling range which is why no probability is
given for it.
From this table, we can see the striking impact that structure has on sta-
bility. In most cases the true probability of stability of each of the fixed
points 2 - 4 is 1.0, so the fixed point is guaranteed to be stable whenever
it can be reached from the starting point. Comparing this with the i.i.d.
distribution we have constructed by permuting all Jacobian entries, we see
a dramatic decrease in the probability of stability, in most cases the i.i.d.
probability of stability is very close to 0.
In the case of the independent Jacobian distributions, we see that the sta-
bility probabilities are the same as, or slightly less than, the true stability
probabilities. This tells us that it is the variance between entry distribu-
tions, rather than the dependencies between them, that crucially controls
the stability of these models. These di↵erences between variance in the
Jacobian’s entry distributions and dependencies are highlighted in Figure
4.3.
So by imposing structure we can bestow stability onto a system. Given a set
of relationships between species (in this case described by an ODE model),
we see that the species can be stable to perturbations about their fixed point
values. If we take this same set of species and link them at random rather
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than according to some interaction scheme, this stability is lost. In his
original paper, May (1972) hinted at how structure can improve stability:
discussing the improved stability of those multi-species communities that
were ‘arranged in “blocks”’. Here we have demonstrated with examples how
stability can be imposed by structure. The limitation of these results is that
we are not able to distinguish between fixed points 2 - 4 of these models
in terms of their stability probability. In the discussion we will consider
how we arrived at these results and look at ways to distinguish between the
fixed points.
4.5.3 Di↵erent parameter regimes control the
proportion of progenitor and di↵erentiated
cells at steady state
For two of the models under investigation here, S6 and S8, there are two
steady states – fixed points 3 and 4 – that yield positive population sizes
for all of the species. In this section we consider only these biologically
interesting fixed points; we are not interested in fixed point 1 (the origin)
or fixed point 2 (not reachable for any parameter values sampled). We then
investigate what parameter values can give rise to each of these two fixed
points; in doing so we can characterise the behaviours that lead to them.
First we studied whether, for any parameters sampled, we are able to reach
both fixed points with positive population sizes for all species. This bista-
bility would be interesting to characterise by studying those parameters
that permit it and linking them to behaviours of the system. In this case
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Figure 4.7: Production rates of progenitor and di↵erentiated cells a↵ect the
steady state reached. Histograms of parameter values that lead to one of
two fixed points for model S6. The first fixed point is characterised by a
higher proportion of progenitor cells (prog. cell bias) and the second fixed
point is characterised by a higher proportion of di↵erentiated cells (di↵. cell
bias). ‘A’ and ‘B’ denote the two possible lineages that stem cells give rise
to. To reach the progenitor cell-biased state, lineage A is favoured, whereas
to reach the di↵erentiated cell-biased state, lineage B is favoured.
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however, there are no such parameters: those that give positive population
sizes for all species at one fixed point do not at the other.
Given that certain parameters lead to one or the other fixed point, but
never both, we look at what di↵erences there are in the distributions of
parameters leading to each. From the total sample of 100,000 parameter
sets, we find that approximately 8000 lead to fixed point 3 and another
approximately 8000 lead to fixed point 4. In order to ascribe significance
to the results we obtain, we need to understand what state each of the
fixed points corresponds to. Recall Figure 4.5.2 for a graphical depiction of
model S6: a stem cell gives rise to two progenitor cell populations, which
here we call A and B to distinguish them, although both lineages have the
same qualitative dynamics. Each progenitor cell population then gives rise
to a corresponding di↵erentiated cell population.
Fixed point 3 corresponds to higher population sizes for progenitor cells by
a factor of 10 – for both lineages – compared with the di↵erentiated cell
populations. Fixed point 4, in contrast, is characterised by higher levels
of di↵erentiated cell populations, again by approximately a factor of 10,
relative to the progenitor cell populations. In Figure 4.7 the distributions
of parameters that give rise to these two di↵erent states are plotted, along
with a description of their meaning.
By studying Figure 4.7 we can describe the di↵erences that lead to one fixed
point or the other. To reach the state dominated by progenitor cells requires
higher production rates of lineage A progenitors than lineage B. It also
requires lower production and death rates of di↵erentiated cells of lineage
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A compared to lineage B. We observe symmetries between the distributions
that lead to each state: to reach the state dominated by di↵erentiated cells
requires the converse rate relations than those just described. That is, a
higher production rate for progenitor cells of lineage B than lineage A, and
lower production and death rates for the di↵erentiated cells of lineage B
than lineage A.
Describing how lineage bias influences the proportions of di↵erent cell
species at steady state is especially interesting given the importance of
branching fates in the haematopoietic hierarchy. The analysis performed
here on fixed points 3 and 4 extends the concept of mapping a model’s basin
of attraction in parameter space. We can find what regions in parameter
space lead to one, or another, fixed point and begin to delineate a boundary
between them. Characterising the behaviour of a model with respect to a
broad area in parameter space, rather than only at some specific values,
enhances our understanding of a model and its potential use. This idea is
developed further in the next chapter where we study qualitative inference
and model behaviour.
4.6 Discussion and conclusions
The relationship between complexity and stability in ecosystems, despite
having a substantial body of research devoted to it over the last 50 years, is
yet to be clearly elucidated (Allesina & Tang, 2012; Elton, 1958; Gardner &
Ashby, 1970; Ives & Carpenter, 2007; May, 1972; Roberts, 1974; Saavedra
et al., 2011). Here, we have shed some light on the matter by dropping the
4.6. Discussion and conclusions 72
i.i.d. assumption that much previous work has been based on, and inves-
tigating the stability properties of systems that we expect to be closer to
the real world in that they exhibit heterogeneity and dependencies between
species.
Performing analyses of these systems, where ‘real world’ properties are be-
stowed by sampling from an underlying ODE model rather than a random
matrix distribution, we find that the probability that their fixed points
are stable is much higher than it would be were these systems rewired
at random. We also find that the heterogeneity between species’ interac-
tions (given by non-identical distributions) – more so than the dependen-
cies between them (given by non-independent distributions) – is important
in determining the system’s stability. We demonstrate the ways in which
structured systems are more stable and thus are able to persist in nature.
This probabilistic stability analysis was applied to a family of 10 simple
model motifs describing the dynamics of interacting stem cell species and
their progeny. The models di↵ered in the total number of species and in the
ways feedback entered the system. We were first interested in characteris-
ing the stability properties of the biologically relevant fixed points of each
model and comparing them. This comparison did not however yield great
insight, because all of the relevant fixed points had a stability probability
of (or very close to) 1. It is possible that the di↵erent feedback motifs that
we considered did not di↵er enough to provide many distinguishable fixed
points. It is also possible that the probability of stability of the biologically
relevant fixed points of a system is robust across a wide class of population
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dynamical models. It would be an interesting next step to address larger
systems of ODEs, or the stability properties of other types of system, such
as delay di↵erential equations.
One of the factors that led to this indistinguishability of the fixed points of
these models was the condition that each fixed point be reachable. When
we do not impose this constraint, the stability probability is lower. This
tells us that there are unstable regions of the model, but that these do not
correspond to biological behaviour regions. These results correspond well
to early work done on the reachability of fixed points by Roberts (1974). In
a similar way to our analysis, Roberts showed using a simple example how
the stability of a system increased when only reachable (feasible) points
were considered.
For two of the models studied here, S6 and S8, two biologically relevant
fixed points were found to be reachable from certain points in parameter
space, and we analysed these two models further. The results are only
presented for S6 however, because the behaviour of S8 was qualitatively
the same, indicating that feedback from di↵erentiated cells onto stem cells
– the distinction between the two models – does not alter the fixed point
behaviour. Our study of S6 found that the balance of progenitor and di↵er-
entiated cells in the system is controlled by the propensity of stem cells to
favour production of progenitor and di↵erentiated cells in one or the other
lineages. Given the multiplicity of haematopoietic progenitor cell species
and the possible interactions between them (Wang & Wagers, 2011; Wilson
& Trumpp, 2006) (see Figure 2.1), such asymmetries are interesting to find
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and could have important implications for haematopoiesis. To analyse this
branching process further, we should compare this model to cell species
data, allowing us to distinguish between the model’s two lineages.
The definition of asymptotic stability used throughout this chapter – that
a system at a fixed point will return to the same fixed point following a
perturbation – at times may not match the biologically ‘stable’ properties
that we aim to describe. One example of such a mismatch is that of os-
cillating systems, which can be stable in the sense of persistence. Another
example is more subtle: if we compare two bistable systems, one where
both fixed points have positive values for all species, and the other where
for one fixed point at least one (or more species) goes to 0, we might wish to
distinguish between them. That is, we might wish to call the perturbation
from one state to another that causes at least one species to vanish greater
(in the sense of being destabilising) that the perturbation that causes a
state change that is not associated with the extinction of any species. This
is an interesting avenue for future work where perhaps di↵erent criteria for
stability could be used that reflect other aspects of biological homeostasis,
such as species’ extinction (Saavedra et al., 2011) or the e↵ects of neutral
mutations (Traulsen et al., 2012).
Currently, our stability analysis relies on deriving analytical expressions for
the fixed points of each model in order to keep computational cost down and
so that we are able to keep track of each fixed point individually. Extending
these methods so that analytical expressions for the system are not required
represents another direction for future work. However, challenges remain,
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such as how to characterise and distinguish each fixed point. If we proceed
numerically, finding the value of each of (say) four fixed points, for a given
parameter set, and then repeat with a new parameter set, we should keep
track of which fixed point is which. This is straightforward when we have
symbolic expressions, but otherwise it is not. Another challenge to address
is that of defining satisfactory distance requirements between numerical
simulation and the fixed point.
Overall, in this chapter we have characterised the behaviour of biologically
motivated systems in a new way, based upon probabilistic analysis of their
fixed points and their stability. We have seen that structure – in the sense
of either an underlying interaction network (ODE model) or heterogeneity
between species – bestows stability on such systems. We argue that both
of these are biological ‘structures’: the former is structured in a natural
sense; the latter is structured in the sense that the interaction terms of
the Jacobian are structured. Some are always 0; some share distributions;
some may have symmetrical or unique distributions. We have shown how
the stability dramatically decreases when structure is removed. We found
this to be the case for all of the stem cell models that we studied here, and
were not able to distinguish their interesting fixed points based on stability
properties alone. For models with multiple biological steady states, we
identified how each could be reached and in doing so mapped out the ‘basins
of attraction’ in parameter space. This provided insight into how branching
decisions in the haematopoietic hierarchy can be made. In the next chapter
we will develop new models based on similar principles to those introduced
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here, and we shift our focus onto competition within the stem cell niche.
Five
Qualitative inference: desirable
behaviour regimes where
leukaemia can be controlled
Parts of this chapter have been published in (MacLean et al., 2013).
5.1 Overview
Haematopoietic stem cells (HSCs) are responsible for maintaining the blood
system throughout life and must be located in their ecological niche (the
bone marrow) to function correctly. In this chapter we propose that cells
with oncogenic potential — cancer/leukaemia stem cells (LSCs) — and
their progeny will also occupy this niche. We study how the dynamical
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relationships between HSCs, LSCs and the progeny of each evolve using
an ecological framework that presents species’ survival within the niche as
a question of competition. Two mathematical models that describe the
dynamics of these species allow investigation into the conditions necessary
for defeating a malignant invasion of the niche. To characterise the models’
behaviour we employ an inferential framework which allows us to study
regions in parameter space that give rise to desired behaviour together
with an assessment of the robustness of the dynamics. Using this approach
we map out conditions under which HSCs can outcompete LSCs. We do
this in a qualitative manner: we search for behavioural conditions rather
than single trajectories. In therapeutic applications we clearly want to
drive haematopoiesis into such desirable regimes and the current analysis
provides some guidance as to how we can identify new therapeutic targets.
Our results maintain that sustaining a viable population of HSCs and their
progeny in the niche may often already be nearly su cient to eradicate
LSCs from the system.
5.2 Introduction
In this chapter, models are developed and studied that descibe the be-
haviour of HSCs and their progeny under competition from malignant
species – leukaemia stem cells (LSCs) and their progeny. As has been de-
scribed previously, the key characteristic of an HSC is its stemness. Here,
HSCs and LSCs share this characteristic and are modelled accordingly.
HSCs and – we assume here – also LSCs are characterised by their de-
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pendency on the niche. In stem cell biology, the HSC niche comprises the
complete set of environmental signals originating from HSC progeny, bone
marrow stroma cells and other factors that regulate HSC function (Wang &
Wagers, 2011; Wilson & Trumpp, 2006). There has been much recent work
on specifying the location of the HSC niche within the bone marrow (Fors-
berg & Smith-Berdan, 2009; Renstrom et al., 2010; Trumpp et al., 2010)
and identifying the cells and features that characterise the HSC niche, see
Chapter 2 for full discussion.
Owing to the uncertainty about the anatomical constituents of the niche, an
ecological approach is taken here. In ecological terms, a niche refers to the
position of an organism within its environment defined by its habitat and
the finite set of resources available to it. It is this broader definition that we
will adopt throughout this analysis. Our modelling approach is thus flexible
enough to encompass unknown components because these are (implicitly)
contained within the definition of an ecological niche as considered here.
We will argue below that this ecological perspective allows us to capture
essential aspects of HSC biology and, in particular, the interplay between
normal HSC lineages and leukaemic stem cells and their progeny.
Leukaemia, a cancer of the blood, which can occur in all types of blood cell,
originates in the bone marrow (Franks & Teich, 1997). As introduced in
Chapter 2, it is proposed that leukaemia is driven by LSCs that occupy a
niche close to (or the same as) the HSC niche. Given this situation, it is
natural to suggest that there exists competition between HSCs and LSCs
for niche space and resources (such as interactions with niche-maintaining
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cells). Studies have found evidence for such competition using an induced
leukaemia mouse model, (Lane et al., 2011) and in cases when HSCs are im-
paired either as a result of ageing or irradiation (Henry et al., 2010; Marusyk
et al., 2009). Although much attention has been paid to the molecular sig-
nalling and regulatory pathways controlling HSC behaviour and, to a lesser
extent, how LSCs could interact with and disrupt this behaviour, to our
knowledge there have been few studies that have framed this problem in
terms of ecological competition (despite the fact that an increasing number
of mathematical and computational approaches are gaining a foothold in
stem cell biology (Aı¨nseba & Benosman, 2011; Daukste et al., 2009; Du↵
et al., 2012; Enderling et al., 2009; Johnston et al., 2010; Sieburg et al.,
2011; Sole´ et al., 2008; Wolkenhauer et al., 2011)).
The keys aims of this chapter are to elucidate the cell intrinsic factors
that exert the greatest influence over the species they control, under the
e↵ects of competition from other species within the niche. The basic math-
ematical analysis of ecological competition between multiple species is now
well developed, and a host of analytical results have been obtained for the
canonical models (Hofbauer & Sigmund, 1998; May, 1973b). There is a
large body of work on the gene regulatory pathways that are involved in
haematopoiesis and the related cancers (see e.g. (Aı¨nseba & Benosman,
2011; Chaidos et al., 2012; Dalerba et al., 2007; Roy et al., 2012)); we
take a slightly higher population-level view. In doing so we hope to ad-
dress another aim which is to identify types of intervention that will allow
us to better understand and control the di↵erentiation and proliferation
5.2. Introduction 81
of competing HSCs and LSCs. The current perspective complements the
molecular and mechanistic studies which are aimed at elucidating cellular
decision making processes. The population dynamics of cell lineages set
constraints on the range of the dynamical behaviour of HSCs and their
di↵erentiation/proliferation behaviour and vice versa.
Whereas for some biological systems there is a wealth of data against which
models can be fitted or compared to, in other cases we have to base our
analyses on less detailed information. Here, rather than estimating param-
eter values from what might be insu cient or irrelevant information, it is
prudent to take a more general approach. With a few notable exceptions
(Boisset et al., 2010; Lo Celso et al., 2009b; Paik & Zon, 2010; Wang et al.,
2003), we are not yet able to identify native HSCs in vivo with confidence
and gather extensive amounts of data. It is possible to study leukaemia in
mice, but the experimental models available do not fully reflect the dynam-
ics of leukaemia development taking place in patients. Xeno-transplantation
of human leukaemia cells into immunocompromised mice is widely used,
but it leads to inconsistent engraftment levels and does not take into ac-
count the role of the immune system in recognising leukaemia development.
Host conditioning prior to injection of human and mouse leukaemia cells
is also widely used and provides a far-from-physiological starting point for
the development of the disease. In experimental models that do not use
conditioning, such as transgenic mice, leukaemia is initiated through ex-
pression of a driving oncogene in a specific cell population and not in a
single leukaemia initiating clone through the use of artificial promoters.
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These initial conditions are very di↵erent to what we would expect to see
in leukaemia patients where disease will typically arise from mutations in a
single cell or lineage. Furthermore, recent results (both experimental and
theoretical) suggest that within a population of cancerous cells it may be
hard to determine which proportion of cells exhibits stemness (Johnston
et al., 2010; Quintana et al., 2008).
For these reasons we proceed to explore large regions of parameter space
and characterise the solutions they produce, rather than investigate models
based upon any particular parameter set. By analysing models according to
distinct outcomes which we select, we can test their robustness with regards
to changes in input. We are thus able to home in on dynamical regimes that
exhibit certain types of behaviour in a computational a↵ordable manner
(even when other tools such as bifurcation analysis would be inappropriate
because we are interested in quick responses). This, we propose, allows us
to suggest new ways for therapies to coax the behaviour in the HSC niche
into certain desirable directions.
5.3 Model development
5.3.1 Model assumptions
HSCs (species x0 in the model) are ancestors of all types of blood cells, a
diverse set performing many di↵erent functions (Wang & Wagers, 2011).
Here we are not investigating all the possible blood cell fates, but the gen-
eral mechanism of blood cell production; therefore we do not consider each
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type of blood cell individually, but group them all under the category of
terminally di↵erentiated blood cells (x2). In between these and the stem
cells, we group together all haematopoietic progenitor cells that are lin-
eage committed and progressively lose self-renewal capacity (x1). For the
questions under investigation in this work, this coarse-grained version of
the haematopoietic tree is su cient (Mangel & Bonsall, 2008). All species
are produced within the bone marrow ecological niche, but the population
of di↵erentiated cells, x2, will leave the niche at a high rate as these cells
enter the blood stream; in healthy adult humans, for example, some 2 mil-
lion new erythrocytes enter the bloodstream from the bone marrow every
second (Sompayrac, 2008).
Complementary to this model of the healthy haematopoietic system, we
model leukaemia as two sub-populations of cancer cells, y0 and y1. Here
y1 are terminally di↵erentiated leukaemia cells and y0 are proliferating
leukaemia cells. We will mainly refer to the y0 population as LSCs but in
fact in our coarse-grained model y0 represents any cell population driving
the growth of leukaemia, including pre-LSCs, LSCs or leukaemia progen-
itor cells. This is important because both pre-LSCs and progenitor cells
transforming to LSCs have been observed to play a role in the progression
of leukaemias (Krivtsov et al., 2006; Lane et al., 2011).
We do not model the intermediate stage in leukaemia di↵erentiation explic-
itly (leukaemic species analogous to the healthy progenitor population x1).
Progenitor cell species x1 is included because we are interested in how its
dynamics change during disease progression; the e↵ects of healthy species
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of a leukaemic progenitor population are of less interest. Furthermore, in-
cluding an intermediate leukaemia species does not qualitatively change the
results that are obtained.
5.3.2 Niche competition
Competition models are based upon the ideas introduced by Lotka and
Volterra and later ecologists, who consider two or more species that rely on
the same limited (environmental) resource for their survival and prolifera-
tion (Hofbauer & Sigmund, 1998; May, 1973b; Roughgarden et al., 1989).
In the case of haematopoiesis, this resource is the niche space available
to stem cells, defined through the molecular signals necessary to maintain
correct function (Wilson & Trumpp, 2006).
In general terms, the competition, which exists between two species, X and
Y , where x and y define the population size of each type, can be expressed
in mathematical form as
dx
dt
= x(↵   (x+ y)) (5.1)
dy
dt
= y(     (x+ y)),
where ↵ and   represent the growth rates of species X and Y , respectively,
  is the strength of the feedback signal and ↵,  ,     0; further examples of
competition are given in Hofbauer & Sigmund (1998). This system assumes
that the e↵ect from feedback is linear and that both X and Y experience
feedback proportional to the combined population sizes of the two species.
In a more general case, the feedback e↵ect from (x+ y) could vary for each
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progenitor
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Model M1A
stem cells terminally
di erentiated cells
x0 x1 x2
y0 y1
Full niche
Figure 5.1: Diagrammatic representation of stem cell competition within
the bone marrow niche. Normal haematopoiesis occurs through HSC (x0)
self renewal and di↵erentiation to produce progenitor cells (x1) that in turn
di↵erentiate into mature blood cells (x2). Alongside this healthy lineage,
there exists a pool of mature leukaemia cells (y1) that is maintained by self
renewing LSCs (y0). Mature cells are able to leave the niche by migration
into the blood stream. Bold/dashed lines represent di↵erent possible niche
boundaries. Note that cell-cell feedbacks are not shown here.
species, or the individual contributions could be altered. In this (simple)
example the equilibrium solutions can be trivially characterised. For all
solutions with ↵ 6=   the species with the greater growth rate will dominate
and the other will go to zero. If Equation 5.1 is generalised so that the
feedback parameters for each term vary, coexistence or bistability (in which
case the initial conditions a↵ect the steady state taken up by the system)
are also possible.
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5.3.3 Model A
In Model A we describe five species with competition modelled by linear
feedback. The first three species are haematopoietic stem cells (x0), progeni-
tor blood cells (x1) and terminally di↵erentiated blood cells (x2). Leukaemic
stem cells (y0) and fully di↵erentiated leukaemia cells (y1) complete the set;
see Figure 5.1. The equations which fully specify the dynamics of Model A
are given below.
x˙0 = axx0(k   z)  bxx0 (5.2)
x˙1 = bxx0 + cx1(k   z)  ex1
x˙2 = ex1   fx2
y˙0 = ayy0(k   z)  byy0
y˙1 = byy0   gy1
Here z = x0 + x1 + x2 + y0 + y1, the parameter set (ax, bx, c, e, f, ay, by, g)
characterises the phenotypes of the five species involved (see Table 5.1) and
k represents the so called carrying capacity, i.e. the total number of cells
that can exist within the bone marrow. In this case k is ‘hard’ in the sense
that it provides an exact upper limit for the total population size of the
niche (In model B below, the carrying capacity is ‘soft’ and is not equal to
the maximal total population size). In simulations k = 1 is used such that
the population sizes are given as concentrations.
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Symbol Definition
ax Rate of self renewal of x0
bx Rate of transition x0 ! x1
c Rate of self renewal of x1
e Rate of transition x1 ! x2
f Rate of disappearance of x2
ay Rate of self renewal of y0
by Rate of transition y0 ! y1
g Rate of disappearance of y1
Table 5.1: Description of parameters that describe model A.
5.3.4 Model B
Model A appeals due to its simple form which ought to facilitate explanation
of its behaviour. There are, however, certain aspects of the haematopoietic
system which have not been included but which will be important biologi-
cally (and mathematically due to the e↵ects they would have on the dynam-
ics of the system). These are addressed with our second model. Here stem
cell fates are modelled explicitly; that is, the terms controlling the rates of
symmetric renewal (x0 ! 2x0), asymmetric renewal (x0 ! x0 + x1), sym-
metric di↵erentiation (x0 ! 2x1) and loss of x0 (x0 ! ;) are incorporated
explicitly (similarly for y0). This is in contrast to, for example, ax in model
A which accounts for production of HSCs by any means. This allows for
more detailed investigation of the relationships between fate choices, at the
cost of increasing the size of the parameter space. Mangel & Bonsall (2008)
model HSCs and their descendants in a similar fashion. There, feedback
terms associated with stem cell fates were given an exponential form; in
model B this form is adopted. It is arguably more realistic that as the
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niche fills (or becomes crowded) the feedback e↵ect increases faster than
linearly, due, for example, to complex patterns of feedback from other cells
in the niche.
The third important distinction between the models regards the form of
the niche. Within the bone marrow niche the location of HSCs (and LSCs)
may be limited to specific sub-regions governed by particular signals (Aguila
& Rowe, 2005; Calvi et al., 2003). In order to capture this behaviour we
separate the feedback terms into one containing the stem cell species, and
one containing all other species.
The assumption that there exists no overlap of species between these sub
niches may be oversimplifying matters in principle, but ought not to mat-
ter in practice as we will argue later. Thus, for the present at least, this
assumption is upheld, also in an attempt to keep model complexity under
control and maintain parsimony. Equation 5.3 describes the dynamics of
model B, and Equation 5.4 specifies the form of the feedback.
x˙0 = x0 1( 1    3 3)  µ4x0 (5.3)
x˙1 = x0 1( 2 2 + 2 3 3) + ( 5   µ6)x1
x˙2 =  1µ6x1   µ8x2
y˙0 = y0 1(1   3 3)  ⌫4y0
y˙1 = y0 1(2 2 + 23 3)  ⌫8y1,
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where
 1( 1, x0, y0) = e
  1(x0+y0) (5.4)
 2( 2, x1, x2, y1) = e
  2(x1+x2+y1)
 3( 3, x1, x2, y1) = e
  3(x1+x2+y1)
The parameter set required to fully specify the phenotypes of these species
is now
( 1, 2, 3, µ4, 5, µ6, 1, µ8,1,2,3, ⌫4, ⌫8,  1,  2,  3). These quantities are
described in Table 5.2. In addition, in Table 5.3, an explanation is provided
for each term included in Equation 5.3, with a description of the e↵ects
of feedback on this term, as controlled by di↵erent cell populations in the
model.
In our model analysis, the first 13 of these parameters are varied; for sim-
plicity we assume that  1,  2 and  3 which control feedback are identical
and held fixed at the values  1 =  2 =  3 = 0.01 (resulting in an arbi-
trary rescaling of other parameters). Equation 5.4 that defines the feed-
back terms, accounts for the e↵ects of the occupants of each sub niche on
all di↵erentiating species (x0, x1 and y0).  1 describes the e↵ect of x0 and
y0 on themselves;  2 and  3 describe the e↵ects of x1, x2 and y1 on the
di↵erentiating species.
The models presented here rely on certain other key assumptions which
ought to be made explicit. The forms of y0 and y1 are similar to their
healthy counterpart species: x0 for y0 and x1 or x2 for y1. Model A assumes
that only x2 or y1 can leave the niche by migration. This is not the case for
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Symbol Definition
 1 Rate of symmetric renewal of x0 (x0 ! 2x0)
 2 Rate of asymmetric renewal of x0 (x0 ! x0 + x1)
 3 Rate of symmetric di↵erentiation of x0 (x0 ! 2x1)
µ4 Rate of migration/apoptosis of x0
 5 Rate of amplification of x1
µ6 Rate of disappearance of x1
 1 Rate of transition of x1 ! x2
µ8 Rate of migration/apoptosis of x2
1 Rate of symmetric renewal of y0 (y0 ! 2y0)
2 Rate of asymmetric renewal of y0 (y0 ! y0 + y1)
3 Rate of symmetric di↵erentiation of y0 (y0 ! 2y1)
⌫4 Rate of migration/apoptosis of y0
⌫8 Rate of migration/apoptosis of y1
 1,  2,  3 Terms controlling feedback strength
Table 5.2: Description of parameters that describe model B.
model B, where all species can migrate or die. In model A, y1 has the same
form as x2; in model B, y1 is expressed as a combination of the structure of
x1 and x2. That is, y1 is produced directly from y0 but cannot self-replicate.
5.4 Methods
5.4.1 Parameter sampling and qualitative inference
The problem of classifying the steady state solutions of models of complex
systems is often substantial. However the rewards of such e↵orts — a qual-
itative analysis of the results a model may provide — are great. Analytical
expressions for the steady states can be obtained by solving the system of
ODEs after setting each equation to 0.
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Term Sign Explanation E↵ects of feedback
x0. 1. 1 + x0 growth x0, y0 " )  1 #
) decrease in growtha
x0. 3. 1 3 – x0 di↵. (sym.) x0, y0 " )  1 #
) decrease in di↵.a
x1, x2, y1 " )  3 #
) decrease in di↵.b
x0.µ4 – x0 loss
x0. 2. 1 2 + x1 production (asym.) x0, y0 " )  1 #
) decrease in productiona
x1, x2, y1 " )  2 #
) decrease in productionb
x0.2 3. 1 3 + x1 production (sym.) x0, y0 " )  1 #
) decrease in di↵.a
x1, x2, y1 " )  3 #
) decrease in di↵.b
x1. 5 + x1 growth
x1.µ6 – x1 loss
x1. 1µ6 + x2 production
x2.µ8 – x2 loss
y0.1. 1 + y0 growth
y0.3. 1 3 – y0 di↵. (sym.)
y0.⌫4 – y0 loss
y0.2. 1 2 + y1 production (asym.)
y0.23. 1 3 + y1 production (sym.)
y1.⌫8 – y1 loss
Table 5.3: Explanation of the terms of Equation 5.3 (model B). All terms are
presented in the form (species ⇥ rate ⇥ feedback control). Feedback control
of the terms controlling leukaemic species (y0, y1) are qualitatively similar
to those for (x) and so are not repeated. Notation: di↵. is di↵erentation;
sym. is symmetric; asym. is asymmetric.
adue to saturation of the stem cell compartment.
bdue to saturation of the progenitor/di↵erentiated cell compartment.
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By sampling parameter sets and simulating a model from these, we can
obtain unbiased dynamical trajectories as examples of a model’s behaviour
that we can classify, according to some suitable criteria. Here we clas-
sify trajectories according to whether HSC lineages win, LSC lineages win,
or neither lineage wins (either due to coexistence, bistability or because
the result falls into neither category). Obtaining enough samples for such
outcome-clustering to be meaningful, however, may be di cult in prac-
tice whenever the number of parameters a↵ecting the system’s dynamics
exceeds five or six. We can use Latin hypercube (LH) or Sobol sampling
approaches in order to sample more evenly over the entire parameter space,
but even so coverage is often too sparse (Santner et al., 2003). For a model
with 10 parameters, for example, we require in excess of 1, 000, 000 samples
to obtain just 4 samples per dimension. Four di↵erent possible sampling
regimes are shown in Figure 5.2.
Furthermore, even given successful classification of a model’s solutions, dis-
secting or further analysing such clustering within a high dimensional space
is challenging. This is particularly true when we are investigating parame-
ters that vary over orders of magnitude. For these reasons, we proceed using
a targeted approach to determine the biological relevance of the solutions
each model provides.
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(a)
✓1
✓2
(b)
✓1
✓2
(c)
✓1
✓2
(d)
✓1
✓2
A B
DC
Figure 5.2: Exploring model space through di↵erent parameter sampling
regimes. (A) Random sampling draws from a multivariate uniform distri-
bution to cover the two dimensional parameter space of ✓1 and ✓2. This is
the most general (undirected) approach. (B) Subdividing the space using
a Latin hypercube allows for more even sampling over the parameter range.
(C) Quasi-Monte Carlo sampling based on the Korobov sequence defining
a low discrepancy point set. In certain circumstances such methods outper-
form simple MC approaches such as (A) and (B). (D) In contrast to the
global approaches of (A) - (C), ABC sampling is targeted towards regions
of acceptable model behaviour, as represented by the blue circles growing
brighter with each iteration. The advantage of such an approach is that
time is not wasted searching through those areas of space that we are not
interested in.
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5.4.2 Robustness analysis via approximate Bayesian
computation
Rather than following such a global (but non-adaptive) sampling strategy,
we can target our investigation by systematically identifying regions in pa-
rameter space where a model produces some desired behaviour. That is,
rather than fitting a model to experimental data, we specify (surrogate) data
which correspond to a system state which we are interested in. The condi-
tions under which this type of behaviour is realised are initially unknown
but can be identified with approximate Bayesian computation (ABC). Orig-
inally developed for cases where computing the likelihood is not feasible,
which is often the case for large, complex systems, ABC methods provide
a convenient solution (Toni et al., 2009) to identify those parameters that
have a high probability of having generated the data. ABC methods forego
evaluation of the likelihood in favour of comparing real with simulated data
(Beaumont et al., 2002; Marjoram et al., 2003). If simulated data x0 for
some parameter value ✓0 is found to be in good numerical agreement with
the observed data, x0, then ✓0 is accepted as a valid draw from the (un-
known) posterior distribution,
PABC(✓|x0) / 1( (x0, x0)  ✏)f(x0|✓)⇡(✓), (5.5)
where ⇡(✓) summarises our prior knowledge/expectations on ✓ and f(x0|✓)
is the data-generating model,  (a, b) is a suitable distance function and
✏ our tolerance level, which determines how closely real and simulated
data have to agree. ABC methods can also be employed in the context
of Bayesian model selection in order to choose the best model (given the
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data and compared to the alternative models considered) (Toni & Stumpf,
2010). Bayesian model selection approaches strike an implicit balance be-
tween the predictive power of a model, its complexity (by favouring more
parsimonious models over larger models unless these describe the data sig-
nificantly better), and robustness. However, the same approach can also be
used to scan models for the ability to generate certain outcomes. Here we
are interested in situations where there is competition between HSCs and
LSCs, and in particular we want to understand under what conditions the
‘ecological’ interactions between the two cell types (and, of course, their
progeny) favour the HSCs and ideally result in suppression of LSCs.
To this end we use qualitative inference to seek to determine P (✓|y0 = 0):
the probability distribution over model parameters ✓, that — reliably and
e ciently — yields loss of LSCs (and stable HSC pools). Our method is
qualitative in the sense that we do not fit our model to surrogate data,
instead we fit it to criteria that specify the behaviour we require: stable,
positive populations of healthy cell species and vanishing populations of
leukaemia species.
The ABC Sequential Monte Carlo (SMC) sampler of Toni et al. (Toni
et al., 2009) allows us to do this and is already implemented in the ABC
Sys-Bio package (Liepe et al., 2010). ABC SMC proceeds by approximat-
ing the posterior distribution, P (✓|x) (where x is some data or specified
system behaviour), in an iterative (sequential) fashion. Compared to other
sampling methods of large-dimensional parameter spaces, e.g. random, LH
and Sobol sampling (Santner et al., 2003), these Bayesian methods have
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the advantage of homing in on regions in parameter space that have a high
probability of resulting in the desired or observed outcome and do not waste
much time on exploring the generally vast regions of parameter space that
do not lead to the specified outcome, see Figure 5.2. The sequential nature
of the SMC framework also incorporates a natural adaptive/learning com-
ponent, which here allows us to assay potential model behaviour e ciently
and comprehensively (Barnes et al., 2011).
5.5 Results
5.5.1 Simulation of models with fixed parameters
gives biologically relevant trajectories
As a first step, we sought to determine whether, given certain specified
parameter values, models A and B will predict species’ dynamics that are
realistic and plausible. Parameter values were set using estimates obtained
from literature where possible, and where reliable estimates could not be
made, values were assigned heuristically. We proceed with this analysis
to demonstrate that model simulations yield results that are realistic and
meaningful. We do not however assign significance to the values chosen
here; in the subsequent section parameter values are not set but are inferred
based upon the behaviour we want to observe.
For the self renewal rate of HSCs, we are able to obtain a value based upon
the work of Wilson et al. (2008) who identify distinct populations of active
and dormant HSCs and find that the populations have predicted doubling
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Par HSC win LSC win Par HSC win LSC win
ax 0.27 0.09  1 0.18 0.15
bx 0.15 0.2  2 0.1 0.1
c 0.3 0.3  3 0.04 0.04
e 0.2 0.4 µ4 0.05 0.15
f 0.15 0.4  5 0.1 0.1
ay 0.27 0.27 µ6 0.15 0.15
by 0.2 0.2  1 0.1 0.1
g 0.3 0.3 µ8 0.01 0.01
1 0.18 0.18
2 0.1 0.2
3 0.04 0.04
⌫4 0.2 0.1
⌫8 0.15 0.15
Table 5.4: Models A and B produce plausible dynamics for heuristically
chosen parameter values. Parameter values given are used for simulation
of model A (left) and model B (right) for the two scenarios of the healthy
lineage triumphing (HSC win) and the disease lineage triumphing (LSC
win).
times of 36 days and 145 days, respectively (from the fit of a model to their
data). This study also estimates that the fraction of active HSCs is 0.85 and
the fraction of dormant HSCs is 0.15. From these figures we find an estimate
for the proliferation rate of HSCs by taking the mean of the active and
dormant fractions: HSC proliferation rate = 0.012 day 1 or 0.09 week 1. It
was not possible to find reliable estimates for progenitor/di↵erentiated cell
production rates from literature: these processes have yet to be successfully
quantified. The corresponding parameter values were set to reflect the need
for larger haematopoietic populations as we move down the hierarchy. In
most cases, values were kept to be the same in the healthy and leukaemic
lineages.
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In Table 5.4 are given the full parameter sets used for the simulations vi-
sualised in Figure 5.3. For both models, rates between the lineages were
kept equal for some processes, and changed in those cases where biologically
there is motivation to do so. The timescale used here is weeks. In model A,
we assume that the proliferation rate of LSCs will be considerably higher
than that of HSCs, so it is set to 3⇥0.09. This led to the leukaemic lineage
taking over the niche at the expense of the healthy lineage. In order to sim-
ulate an HSC-enhancing treatment, we take ax ! 3ax (so ax = ay = 0.27)
and decrease the rate of production of x2 (thus keeping a larger propor-
tion of healthy stem/progenitors), this leads to successful eradication of the
leukaemia lineage.
A similar analysis is performed for model B. Since here we explicitly model
stem cell self renewal, asymmetric di↵erentiation and symmetric di↵erenti-
ation, the estimated proliferation rate of 0.09 week 1 is split between these
processes, with lower weighting given to the di↵erentiation processes. Sim-
ilarly to model A, by decreasing healthy di↵erentiated cell production we
enable eradication of leukaemia from the niche. If the leukaemia pool is
boosted by an increase in asymmetric di↵erentiation (2), this allows the
leukaemia lineage to beat the healthy species. The trajectories for each
simulation are shown in Figure 5.3.
From these simple simulations we see that, given parameter values taken
either from literature or chosen heuristically, we can recover niche dynaimcs
of the sort that we expect to observe for di↵erent conditions in vivo. Given
this proof of principle, we proceed to look at model behaviour globally,
5.5. Results 99
!"#$%&'$$()*%
+,
$-
"$
).
%-
/0
-$
01
23
4/
0%
5
/6
$7
%8
%
5
/6
$7
%9
%
:$;(3$#"3%7"0$3<$%'"0)% =$371>?%7"0$3<$%'"0)%
Figure 5.3: Simulated trajectories for the species of models A and B under
di↵erent conditions. On the left are shown simulations for models A and B
under conditions where the leukaemia lineage wins and drives the healthy
lineage to extinction. On the right are shown simulations for another sce-
nario where the healthy lineage outcompetes the leukaemic one. Notation:
S, HSCs; A, progenitor cells; D, di↵erentiated cells; L, LSCs, T, leukaemia
di↵erentiated cells. For parameter values used to simulate see Table 5.4.
guided not by certain parameters but certain desirable behaviours.
5.5.2 Desirable regimes reveal distinct dynamics for
HSCs and LSCs
Here we investigate the circumstances under which the two models favour
HSCs whilst suppressing LSCs, that is x0, x1 and x2 > 0 and y0 = y1 = 0
on reaching steady state. Each parameter was sampled from a uniform
prior distribution in the range [0, 1]. The posterior distribution that we
obtain shows the regions of parameter space that are most likely to suppress
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leukaemia. Each parameter is described by a histogram; pairs of parameters
can be visualised on 2 dimensional density plots. This is illustrated in Figure
5.4A.
Overall we see that those parameters controlling LSC dynamics are less
well inferred (less peaked) than those controlling HSC dynamics. This sug-
gests that requiring a species to die out is a less stringent condition than
requiring a species to reach some finite population size, as is the case for
haematopoietic species x0, x1 and x2. A comparison between the parame-
ters controlling healthy and leukaemia dynamics is shown in Figure 5.4B.
The full set of results for model A is given in Appendix A.
The posteriors that we obtained appear to be unimodal. Therefore it is
possible to perform principal component analysis (PCA) on the posterior
distribution for the parameters in order to evaluate the robustness of these
systems to (joint) changes to parameters (Erguler & Stumpf, 2011; Secrier
et al., 2009). (It is not advisable to perform PCA on multimodal datasets
as the technique is not designed to capture the multimodality.) The princi-
pal components are constructed by finding the eigenvalues and eigenvectors
of the covariance matrix of the parameters. The first principal component
(corresponding to the largest eigenvalue) corresponds to the direction where
the posterior is widest; the last principal component (corresponding to the
smallest eigenvalue) points into the direction of least variance. This pro-
vides us with an indication of those parameters that are tightly constrained
by the imposed/desired system behaviour; i.e. varying these parameters
by even moderate or small amounts can have appreciable e↵ects on system
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Figure 5.4: Properties of the posterior distribution and comparison of pa-
rameter posterior values that allow leukaemia suppression for model A. (A)
Marginal posterior distributions (red histograms) and density plot. (B)
For model A: comparison of marginal posterior distributions for di↵erent
rates controlling healthy and leukaemia cell species. Overall, rates control-
ling leukaemic species are less well inferred than those controlling healthy
species.
output (in the vernacular of Sethna et al. these are the “sti↵” parame-
ters) (Gutenkunst et al., 2007). Here these smallest principal components
are of primary interest unlike in most cases where PCA is used to try to
identify parameters that control the largest variance in the data (i.e. dis-
tinguish between outcomes). Such “sloppy” parameter (combinations) are
less critical for determining system dynamics and may sometimes even not
be identifiable (i.e. extend over the whole prior range).
For model A, the majority of the last principal component (56%) was com-
posed of contributions from the parameters ax, bx and e. The second last
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Figure 5.5: Parameter posterior values that allow for leukaemia suppression
under model B. Shown are parameter ranges for healthy and leukaemia
stem cell rates that allow suppression of leukaemia to occur. For HSCs,
self renewal and symmetric di↵erentiation should be controlled. For LSCs,
little to no control is required. See Figure 5.4A for explanation of the plots.
principal component was mainly composed (63%) of e and f . So, given
our analysis of the posterior via PCA, in order to suppress leukaemia by
populating the niche with healthy blood cells, it is most important to ob-
serve specific rates of the production of progenitor blood cells, self renewal
of the stem cells that are producing them, production of terminally di↵er-
entiated cells from progenitor blood cells and the migration/death of these
di↵erentiated cells.
For model B, the 13 free parameters were also sampled from uniform priors
on [0, 1]. Parameters controlling healthy cell dynamics are better inferred
than parameters controlling leukaemia. As in the case of model A, the
constraint y0, y1 ! 0 at equilibrium is more easily met than the constraint
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for HSC species to reach a finite positive value above some threshold. In
Figure 5.5 the posterior distribution for the stem cell dynamics is shown.
The full output for model B is shown in Appendix A.
We see in Figure 5.5 that the posterior for HSC asymmetric di↵erentiation
is uninformative. The result that more information is given about self
renewal and symmetric di↵erentiation rates suggests that controlling the
rate of HSC asymmetric di↵erentiation does not assist in achieving LSC
suppression. Controlling self renewal and symmetric di↵erentiation of HSCs
is su cient in this case. In contrast to the parameters controlling HSC fate,
none of the parameters controlling LSC fate need to be specified in order
to achieve leukaemia suppression.
PCA was also performed on the results for model B. The last principal com-
ponent is dominated (66 %) by  1,  3 and µ4, which collectively control the
fate of HSCs. This suggests that leukaemia can be beaten if a healthy pop-
ulation of HSCs is present. The second last principal component is mainly
composed (64 %) of  5 and µ6. These parameters control healthy progeni-
tor cell (x1) dynamics and are analogous to e1 and f in model A. There is
also a significant contribution (8 %) from ⌫4 to this principal component,
suggesting that of all the parameters controlling leukaemia, the death rate
of LSCs could influence model dynamics the most.
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5.6 Discussion
Here we studied circumstances under which leukaemia stem cells and their
progeny succumb to normal HSCs and their progeny. We have taken a
population-level perspective which models a highly simplified representa-
tion of the ‘ecology’ in the haematopoietic niche. In order to interpret
these results we have to address two questions: first, according to our sim-
plified model, which parameters control the ecological balance, and which
interventions would allow us to shift this balance in favour of normal non-
leukaemic HSCs maintaining themselves and their progeny in the niche?
And second, how can we relate these highly idealised model results to the
processes occurring in the real world? The answer to the second question
must depend on the answer to the first question and we address them in
turn.
The results from both models suggest, perhaps somewhat counterintuitively,
that it is more important to maintain the dynamics of the HSC lineage
within certain bounds than to control parameters related to the LSC lineage.
One reason for this is that there are many scenarios where suppression of
the LSC lineage is possible, for example by assigning leukaemic species
very low growth rates, but where nevertheless the HSC lineage cannot be
maintained, recovers very slowly, or where both lineages co-exist. This is
perhaps the most important lesson emerging from both models.
The models presented here were developed based on the biological feature
set we aim to describe, the crucial components of which are stem cell di↵er-
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entiation, competition for an ecological resource and feedback mediated by
the niche. By characterising solutions according to the lineage outcomes, we
show that we can compare the likelihood of niche dominance by one lineage
or another given a certain model. There are certain regions of parameter
space that produce results that are not permissible biologically, such as in-
finite population sizes. This is the case for model B in the region  5 > µ6,
where results are unbounded. This can be deduced both from ABC pa-
rameter inference, which excludes this region even for large tolerances, and
from simulation. So if species x1 is self-replicating more quickly than it is
disappearing, the system grows in an unstable manner.
The niche (of size K) can be divided into sub-niches, K = K1 + K2 as
there is some evidence that HSCs and by extension LSCs reside in specific
sub-compartments of the (ecological) niche. We must consider whether
this coarse-grained description is realistic, or whether in reality we have
a situation whereby some species move between sub-niches. Our central
findings, however, appear to be robust features of niche-mediated feedback:
in particular we believe that maintenance of the HSC lineage is important
to drive down LSCs and their progeny. In turn, an assault on LSCs and
their progeny on its own will likely not su ce to restore the haematopoietic
system.
There are many di↵erent ways to study the behaviour of a biological system.
In this work we look at a model globally, by performing targeted investi-
gation of its whole behaviour space. This is facilitated by ABC. Thus we
can understand the stability and robustness properties of our system. In
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Kitano (2007), robustness is defined as the ability of a system to maintain
its functions under perturbations, and contrasted with stability which has
the narrower definition of maintaining certain system states. Using ABC
we can characterise not only a system’s stability but also its robustness by
looking at the maintenance of system functions, in this case the survival of
the haematopoietic lineage.
Throughout the analysis of the models presented here, we have been con-
sidering the case where the presence of LSCs is already established. This
should, we feel, include pre-clinical dynamics as well. Small leukaemia pop-
ulations could occur often in the ecological niche and be outcompeted by
healthy species thus restoring normal haematopoiesis. These instances are
interesting because they provide more clues about the conditions favourable
for suppressing an invasion of the niche by leukaemia cells.
Models must strike a balance between simplicity and reality. In the endeav-
our to retain or, more correctly, establish simplicity, many known aspects
of the biology of haematopoiesis have been left out of the current analysis.
For example, more complicated hierarchies and feedback from the periphery
into the niche could be included. However here too, details of the processes
involved are largely unknown, and the explorative use of techniques such as
ABC, which combine the ability to condition on desired or expected (quan-
titative and qualitative) behaviour with an assessment of the robustness of
this behaviour are useful. In the future, such methods will aid experimental
design and enable the study of how external (therapeutic) targets can be
designed to control patterns of HSC di↵erentiation.
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We have investigated the ability of two similar but distinct models to pro-
duce certain behaviours and we ask if they do so in di↵erent ways. From
the results, we find that the results for models A and B are complementary
and that model B, with its added complexity, does not yield significantly
greater insight into the system than (more simple) model A. It seems that
the additional processes of model B – sub-niches, explicit stem cell fate pro-
cesses and exponential (rather than linear) feedback – do not play crucial
roles in determining model outcome: healthy vs. leukaemia lineage winning
in the niche. Thus, although model B provides interesting behaviour, for
reasons of parsimony we will proceed in future analyses with investigation
only of model A.
5.7 Conclusion
In this chapter our main goals were twofold. Firstly, we sought to develop
models of HSC/LSC competition within the niche and methods for their
analysis, and secondly we sought to determine how leukaemia could be erad-
icated from the niche. The models developed built upon the basic structure
of stem cell models illustrated in the previous chapter and extended them
to include competitive e↵ects. Upon completion of our first goal, we were
able to identify favourable niche conditions and we found that controlling
leukaemia lineage dynamics was the most important factor to achieve its
successful eradication from the niche. In the next chapter we will continue
to build upon these ideas of cellular competition, next applied in the context
of biological (clinical) data. We will retain model A (model M1 in Chapter
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6) for future analysis but will not proceed to analyse model B further. Two
new models are additionally presented, along with an investigation into how
di↵erent patients exhibit di↵erent disease outcomes, specifically remission
from – or relapse of – leukaemia.
Six
Ecology in the haematopoietic
stem cell niche determines the
clinical outcome in chronic
myeloid leukemia
Parts of this chapter have been published in (MacLean et al., 2014).
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6.1 Overview
Chronic myeloid leukaemia (CML) is a blood disease that disrupts normal
function of the haematopoietic system. Despite the great progress made
in terms of molecular therapies for CML, there remain large gaps in our
understanding. In this chapter light is shed on certain aspects of this disease
by comparison of models that describe CML in di↵erent ways. This builds
upon the work presented in Chapter 5 by introducing additional methods
used for analysis and applying these methods to study the behaviour of
models, given clinical data describing patients undergoing treatment for
CML.
By comparison of mathematical models that describe CML progression and
aetiology we sought to identify those models that provide the best descrip-
tion of disease dynamics and their underlying mechanisms. The essential
element shared by the models used here to study CML is a description
of the dynamics of healthy and leukaemia stem cell populations and their
progeny within the haematopoietic stem cell niche. Data for two clinical
outcomes – disease remission or relapse – are considered and we investigate
these using Bayesian inference techniques throughout. We find that it is
not possible to choose between the models based on fits to the data alone,
however by studying model predictions we can discard models that fail to
take niche e↵ects into account. More detailed analysis of the remaining
models reveals mechanistic di↵erences: for one model leukaemia stem cell
dynamics determine the disease outcome, whilst for the other model dis-
ease progression is determined at the stage of progenitor cells, in particular
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by di↵erences in progenitor death rates. This analysis also reveals distinct
transient dynamics that will be experimentally accessible, but are currently
at the limits of what is possible to measure. To resolve these di↵erences we
need to be able to probe the haematopoietic stem cell niche directly. Our
analysis highlights the importance of further mapping of the bone marrow
haematopoietic niche microenvironment as the ecological interactions be-
tween cells in this niche appear to be intricately linked to disease outcome.
6.2 Introduction
Chronic myeloid leukaemia (CML) is a blood cancer primarily a↵ecting
the myeloid lineage species of the haematopoietic system. As introduced
in Chapter 2, in the majority of patients it is characterised by a specific
chromosomal translocation: t(9;22)-(q34;q11) (Epstein et al., 1999). This
results in a fusion gene made by combining the breakpoint cluster region
gene (BCR) on chromosome 22 with the Abelson murine leukaemia viral
oncogene (ABL) on chromosome 9. The protein product of this fusion
– BCR-ABL – is a tyrosine kinase with ABL comprising a transmembrane
region. Given the form of the protein, a successful therapy for (BCR-ABL+)
CML has been devised using tyrosine kinase inhibitors (TKIs). These bind
to the ABL domain of BCR-ABL and successfully block growth of BCR-
ABL+ cells (Muller et al., 2003).
The cellular and molecular processes involved in healthy haematopoiesis
must be disrupted in disease (Hu et al., 2009). But there is solid evi-
dence that they operate in parallel to the normal haematopoietic system:
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thus a branch of the haematopoietic system propagates deficient cells and
generates the ensuing pathology, while other cells of the haematopoietic
system continue to operate alongside (Hope et al., 2004; Jamieson et al.,
2004; Lapidot et al., 1994; Wang & Dick, 2005). This is, of course, akin
to problems frequently encountered in ecology. Based on this analogy we
here attempt to understand the interplay between the healthy and CML
systems. This is a particularly helpful perspective if interactions between
healthy and diseased cell types can a↵ect the disease progression, as is now
widely believed.
Interactions will include shared reliance on nutrients, co-factors, and physi-
ological conditions required to maintain stem cell properties. These factors
can be subsumed under the umbrella of the stem cell niche. The dynamics
in the niche determine the abundance of stem cells, and if there are di↵erent
ways in which healthy and cancerous stem cells can exploit or adjust to the
niche environment, then ecological dynamics can influence the progression
of the disease in a way akin to classical ecological dynamics (Mangel &
Bonsall, 2008).
Here we study CML dynamics in light of patients who are undergoing treat-
ment for CML via TKIs. The level of leukaemia in patients is quantified by
measuring the proportion of di↵erentiated leukaemia cells in blood, sam-
ples of which are taken every few months. Our data fall into two di↵erent
categories: data for patients who go into remission, and data for patients
exhibiting relapse. We consider these cases separately in order to identify
possible functional di↵erences that give rise to – or at least are correlated
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with – the di↵erent clinical outcomes.
Disease outcomes are investigated with respect to models that describe both
healthy and leukaemia-related haematopoietic systems. It is assumed that
both lineages are derived from a stem cell population – HSCs and LSCs,
respectively. The models di↵er quite profoundly in the manner in which
they consider interactions (or competition) between di↵erent cell types. We
use an approximate Bayesian computation (ABC) framework throughout to
calibrate models against data and compare their relative performance.
Given detailed analysis of the models, we will see that we can reject those
models that fail to account for niche dynamics explicitly and from the out-
set. Furthermore we can show that the available time course data strongly
suggest an important role of the HSC niche dynamics for CML disease pro-
gression and outcome. We find evidence for the niche e↵ects extending
beyond the HSC/LSC level and also a↵ecting the dynamics of progenitor
and quite possible other cell types in the haematopoietic hierarchy.
6.3 Model development
6.3.1 Model M1 (MacLean et al., 2013) — niche
competition
The first model we consider has already been introduced as model A in
Chapter 5. Here we are going to refer to this model as M1 for consistency
with the others considered in this chapter. This model describes the dy-
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Figure 6.1: Mechanistic models for haematopoiesis in CML. Graphical de-
scription of models M1, M2, and M3. The haematopoietic niche is rep-
resented by a red rectangle: all species inside the rectangle influence the
niche; only species marked by red inhibitory arrows are a↵ected by it. For
model M2 there are no niche e↵ects present. Cell death is illustrated by
light grey arrows.
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namics of five species of interacting cell populations; we will not specify its
details again as these can be found in the previous chapter and in MacLean
et al. (2013). This model is depicted once again in Figure 6.1 for comparison
with models M2 and M3.
6.3.2 Model M2 (Michor et al., 2005) — niche
independence
This model was developed to describe the dynamics of HSCs and LSCs
and their temporal evolution under TKI therapy and contains eight species:
HSCs with three progenitor populations, and LSCs and their corresponding
three leukaemia progenitor populations (Michor et al., 2005). The model is
depicted in Figure 6.1 and the equations that specify it are,
x˙0 = ( (x0)  d0)x0 ⌘ 0 (6.1)
x˙1 = axx0   d1x1
x˙2 = bxx1   d2x2
x˙3 = cxx2   d3x3
y˙0 = (ry(1  u)  d0)y0
y˙1 = ayy0   d1y1
y˙2 = byy1   d2y2
y˙3 = cyy2   d3y3
where x0 are HSCs, y0 are LSCs and the xi, yi for i 2 (1, 2, 3) are progeny
of the two stem cell populations.  (x0) describes a homeostatic function
defined such that x˙0 is constant; u is the number of resistance mutations
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Symbol Definition
M1 ai Self renewal rate of stem cells
bi Production rate of progenitor cells
c Self renewal rate of healthy progenitor cells
e Production rate of healthy di↵erentiated cells
f Death rate of healthy di↵erentiated cells
g Death rate of leukaemia di↵erentiated cells
M3 x¯0 Carrying capacity of the niche
ai Production rate of progenitor cells
bi Production rate of di↵erentiated cells
ci Production rate of fully di↵erentiated cells
ri Growth rate of HSC/LSC (rescaled)
d0 Death rate of stem cells†
d1 Death rate of progenitor cells†
d2 Death rate of di↵erentiated cells†
d3 Death rate of fully di↵erentiated cells†
Table 6.1: Description of parameters used to characterise models M1 and
M3. Parameter symbols used by each model and their meanings are given.
i 2 {x, y} denotes lineage where x is healthy and y is leukaemia. (†) death
rates for model M3 are shared between healthy and leukaemia lineages.
which here is assumed to be 0. (A version of the model that did include
resistance mutations was briefly considered, but mechanistically it o↵ers no
more than the form presented here, since there are no additional interac-
tions between species.) All other parameters are shared by model M3 and
described in Table 6.1. The main assumptions of this model are thus that
each species is produced from its parent species at some rate proportional
to the size of the parent population, and can die at a rate constant to its
own population size. Also, the death rates (d1, d2, d3) are shared between
healthy and leukaemia lineages and ‘death’ here is used as a general term
that can account for cell death, di↵erentiation or migration away from the
niche. In this model there are no regulatory feedback e↵ects.
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6.3.3 Model M3 (Foo et al., 2009) — partial niche
dependence
Model M2 does not allow for competition between HSCs and LSCs: the two
lineages progress independently. In (Foo et al., 2009), a model is introduced
that describes the dynamics of the same eight species as in M2, but here
the growth of stem cells is a↵ected by the population size of HSCs and
LSCs. In this way competitive e↵ects are introduced and dynamics within
the niche are taken into account. The form of model M3 used here is a
rescaled version of the original proposed in (Foo et al., 2009) in order to
allow comparison of the three models considered here, and we have,
x˙0 = ( x   1)d0x0 (6.2)
x˙1 = axx0   d1x1
x˙2 = bxx1   d2x2
x˙3 = cxx2   d3x3
y˙0 = ( y   1)d0y0
y˙1 = ayy0   d1y1
y˙2 = byy1   d2y2
y˙3 = cyy2   d3y3
with
 i =
ri + 1
1 + rix¯0 (x0 + y0)
(6.3)
where i 2 {x, y} and the species (x, y) are the same as for M2. The param-
eters that specify this model are described in Table 6.1. Note that, as for
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Model E↵ectors Niche reliant Unconstrained
M1 all cell types stem and di↵erentiated cells
progenitor cells
M2 – – all cell types
M3 stem cells stem cells progenitor and
di↵erentiated cells
Table 6.2: Di↵erent treatment of species’ niche reliance between models.
The relationship between a species and the niche can be categorised into
the following groups: e↵ectors – can impact the niche; niche reliant – can
be a↵ected by the niche; and/or can be fully unconstrained by the niche.
M1, the di that are referred to as ‘death’ rates in the succeeding analysis
subsume the processes of di↵erentiation and migration out of the niche.
In addition to these three models, we have studied one further established
model that describes interactions between HSC and LSC, including com-
petition, presented in (Roeder et al., 2006). Here similar cellular processes
are modelled but using an agent-based modelling approach. The large com-
putational cost of simulating this model, however, precludes the Bayesian
analysis attempted here.
6.4 Methods
6.4.1 Data processing
CML levels are assayed through measurements of transcript levels of the
BCR-ABL protein in the blood (see Figure 1). Each of the 69 patients
in the study is being treated with tyrosine kinase inhibitors (TKIs) that
selectively bind to the BCR-ABL protein present on CML cells. Blood
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Figure 6.2: Experimental measurements of leukaemia progression in 69 pa-
tients. The change in the BCR-ABL level over time for each patient is
represented by a grey line. The average change over all patients is illus-
trated by a dashed green line; the change in the BCR-ABL level for a pa-
tient who exhibits disease relapse is illustrated by a dashed red line. Model
comparison is based on these two coloured trajectories.
samples are taken every few months although not always at the same time
points across all patients.
The 69 patient trajectories over the time course studied are heterogeneous
(Figure 6.2). We distinguish two distinct outcomes – remission and relapse.
A patient is classified as in remission if the level of CML in the blood is
(strictly) decreasing over time. The remission trajectory used is the mean
over all 69 patients, averaged at each time point where there were at least 20
measurements taken. Behaviour is classified as relapse if an initial decrease
is followed by a pronounced and continuing increase in CML levels. A single
patient trajectory exhibiting such features was used for analysis.
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6.4.2 Bayesian parameter inference and model
comparison
We seek to perform model selection, that is, choose which model best de-
scribes the data that are available to us. There are several di↵erent ways
to do this that are appropriate to systems biological problems (Kirk et al.,
2013). We primarily use a likelihood-free parameter inference approach
– approximate Bayesian computation (ABC) – to fit the models to data.
Additionally, the probability that a given model could explain the data is
computed with a likelihood-based sequential Monte-Carlo algorithm.
The ABC algorithm provided by Toni et al. (2009) allows us to infer the
model parameters. ABC approaches use systematic comparison between
simulated trajectories and the observed data in order to identify parame-
ters associated with simulated trajectories that are closest to the observed
data. The methods in the previous chapter give a more detailed explana-
tion of ABC. Here, the time series for BCR-ABL is compared (using the
Euclidian distance) to the ratio T/(T + 2D) where T is the number of
leukaemia di↵erentiated cells and D is the number of healthy di↵erentiated
cells (Roeder et al., 2006). We use the ABC   SysBio package which pro-
vides a python implementation of this algorithm with GPU support (Liepe
et al., 2010).
Use of a likelihood-based sequential Monte-Carlo sampler (Del Moral et al.,
2006) enables us to compute the model evidence which is the probability to
observe a dataset under a given model. We used our own implementation
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Figure 6.3: Models are not distinguishable based on fits to the data.
Fits to the data (yellow diamonds) for the three models and the two out-
comes. All three models are able to explain the observed leukaemia evolu-
tion for the two outcomes.
of the SMC sampler algorithm in python as well as an interface to simulate
the models in a computational e cient manner using a GPU accelerated
ODE solver (Zhou et al., 2011).
6.5 Results and discussion
6.5.1 Models cannot be distinguished based on fit to
the data alone
By the use of likelihood-free sequential Monte-Carlo Bayesian inference
(Toni et al., 2009), we can perform parameter inference independently for
the three models. As shown in Figure 6.3, the simulated behaviours ob-
tained for each of the three models and two outcomes are very similar to
the observed behaviours. The acceptance threshold between simulated tra-
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Model Remission Relapse
M1 -40.2 (1.2) -25.2 (0.04)
M2 -39.6 (1.6) -25.4 (0.1)
M3 -39.9 (1.9) -25.1 (0.03)
Table 6.3: Ranking based on model probability does not discriminate be-
tween models. Models are ranked by the probability of each to explain the
observed datasets. For each model and each outcome, the logarithm of
the model probability is computed using a sequential Monte-Carlo (SMC)
sampler; the average over 10 independent runs is displayed and the number
in brackets is the standard deviation. There are no significant di↵erences
between the model probabilities according to Je↵reys’ scale.
jectories and observed data was chosen so that the final distance between
the two was lower than ✏ = 4.0 in the case of remission and ✏ = 15.0 for
relapse. From the similarity of the fits, we can say that all three models are
able to explain these outcomes, over some range of parameters.
As a point of comparison with the ABC approach used to test the models, a
likelihood-based Bayesian sequential Monte-Carlo sampler (Del Moral et al.,
2006) was used to compute the model probabilities. To do this we define
a likelihood function for the model giving rise to the observed data, and
specify a noise term (we use an additive Gaussian noise term). We can then
maximise this likelihood function to give us the probability that the model
has given rise to the observed data. This again found no evidence in favour
of any one of the three models. The model probability (log likelihood of
the model given the data) for each case is shown in Table 6.3. According to
Je↵reys’ scale (Je↵reys, 1961), there is no statistically significant di↵erence
between the model probabilities.
6.5. Results and discussion 123
Thus the available data alone does not allow us to decide between the three
models considered here. Therefore we need to consider other properties of
these models coupled with biological reasoning in order to elucidate the
mechanisms underlying CML aetiology and progression.
6.5.2 The importance of competition (model
checking)
The posterior distributions obtained from Bayesian parameter inference al-
low us to predict cell-type behaviour: trajectories of individual species are
simulated using parameter values sampled from the posterior. In Figure 6.4
the trajectories for HSCs and LSCs are plotted for each model in the case
of relapse. Models M1 and M3 both exhibit stem cell species’ dynamics
that reach finite and biological plausible steady states. This is not however
the case for model M2. Here LSCs and all their progeny exhibit unbounded
exponential growth.
Thus model M2 cannot represent the underlying biological mechanisms and
cannot describe the dynamics of the haematopoietic system. Since our goal
is to explain mechanisms of leukaemia growth and decline, we cannot hope
to gain much insight using a model with such drastically implausible growth
kinetics. In light of the behaviour found we can reject model M2 and focus
our further attention on the models M1 and M3.
The distinguishing features of model M2 are related to competition and
reliance on the niche (See Table 6.2). In model M2, species are independent
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Figure 6.4: Simulation of stem c ll dynamics demonstrated the importance
of niche competition. Predicted trajectories for stem cell species for each
model. The lines represent the median of the evolution and the error bars
designate the 5% and 95% percentiles for a set of 1000 parameters sampled
from the posterior distribution. For model M2, LSCs follow exponential
growth for all sampled parameter values.
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from reliance on the niche; there exists no explicit competition between
any species. The rejection of M2 thus suggests that competition between
haematopoietic species is a salient feature of a model that attempts to
describe the dynamics of CML. Although direct competition is not the only
manner by which the population could be controlled; one could also imagine
other feedbacks or saturating functions that have not been modelled here.
In the next section we study in more detail what form these interactions
and competitive e↵ects can take.
6.5.3 M1 and M3 o↵er contrasting mechanisms of
leukaemia suppression (model comparison)
In order to study the di↵erences between models, we exploit the poste-
rior distributions obtained from the parameter inference. It is di cult to
directly identify di↵erences between models from these distributions be-
cause none of the model parameters are strongly inferred, and most of the
parameters are highly correlated (full posterior distributions are shown in
Appendix A); while this may be seen as failure of the inference, it is in
fact, a reflection of the data (their nature, quality and quantity) and is
itself informative. More crucially, perhaps, it highlights the importance of
assessing the uncertainty of estimates instead of merely obtaining “optimal
estimates” of parameter values. In the Bayesian framework we can still
derive useful insights by making the posterior distribution the centre of the
analysis and using it to predict the behaviour of the di↵erent cell-types over
time. The corresponding predicted trajectories for each outcome are shown
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Figure 6.5: Dynamics of model species that lead to either remission or re-
lapse of disease. The predicted change over time of each species for a times-
pan of six years (the total period of the trial), for each model (model M1 in
A & C, model M3 in B & D) and outcome (remission in A-B and relapse
in C-D). For each model and each outcome, 1000 parameter sets have been
sampled from the posterior distribution and each line corresponds to the
simulated trajectory for one of these parameter sets.
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in Figure 6.5.
In the case of remission we note that the mechanisms of modelM3 are harder
to elucidate since here a large variety of behaviours is permitted (Figure
6.5B). Model M3 fitting remission also permits higher species’ concentra-
tions (>> 1) than for any other outcome. Thus, while we can identify the
main mechanisms leading to remission under model M1, direct comparison
of the models’ actions is di cult. For M1, the level of both leukaemia stem
and di↵erentiated cells declines over time, with the di↵erentiated leukaemia
cell level being more tightly constrained (Figure 6.5A). The HSC popula-
tion initially decreases, but after a few time points, di↵erent behaviours —
either HSC increase and decrease — are permitted. There is a sharp initial
peak in the level of healthy progenitor cells, after which the behaviour is
no longer tightly constrained by the parameters sampled from the poste-
rior. This initial peak is also observed for the healthy di↵erentiated cells,
but with greater variance. We observe that disease remission for model M1
is a consequence of suppression of leukaemia species and expansion of the
healthy di↵erentiated cell populations through transient progenitor popu-
lation growth. This prediction is directly testable, i.e. we need to study
healthy blood progenitor abundances over the course of CML treatment to
see whether a growth peak occurs after initial administration of TKIs.
For CML relapse, the species’ behaviours under both models are more con-
strained (Figure 6.5C-D), even though we still have broad posterior distri-
butions. Models can only fit the data for low levels of healthy di↵erentiated
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cells at steady state. We see that for both models the level of healthy pro-
genitor and di↵erentiated cells first increases to explain the temporary sup-
pression of leukaemia, before quickly decreasing. This transient behaviour
occurs more quickly for progenitor than for di↵erentiated cells; there is a
time lag as we move down the hierarchy. In model M1, both stem and
di↵erentiated leukaemia cells initially decrease before increasing to fill –
at least a proportion of – the niche. This transient behaviour of leukaemia
suppression before a return of the disease is in agreement with the literature
on recurrence of CML (Mahon, 2012).
In contrast to model M1, in model M3 leukaemia stem and progenitor cells
can have very di↵erent behaviours. There are also some cases where HSC
levels at steady state can be relatively high (occupying ⇠ 40% of niche
space). This can be due to the number of layers in the hierarchy of M3,
allowing e↵ects originating at the stem cell level to be dampened in succes-
sive progeny levels; the fact that we measure only fully di↵erentiated cells
makes the details of the process hard to identify. The death/di↵erentiation
rates for progenitor and di↵erentiated cells in M3 are all high, meaning
that the populations of each lineage are being exhausted through di↵eren-
tiation, migration and death of cells. The di↵erentiation/death rates for
the leukaemia lineage are slightly higher than for healthy cells. This in-
creased rate of di↵erentiation (or progression through the haematopoietic
hierarchy) seems to be the most plausible explanation for the transient de-
crease of leukaemia, although from these results the mechanism by which
leukaemia returns is unclear. The increased rate of di↵erentiation has, to
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our knowledge, not been reported in the literature although it should be
measurable in principle if it does indeed exist.
Considering the prediction (made by both models) that the di↵erentiated
blood cell population should decline until close to zero in the case of relapse,
we note that this does not imply a total loss of blood because the blood
samples used consisted only of lymphocytes (Muller et al., 2003). The mod-
els predict that in the case of CML relapse, healthy lymphocyte numbers
will be very low, but they do not make a prediction about the population
size of myeloid lineage cells.
6.5.4 CML patient outcomes are controlled by
di↵erent features between models (model
comparison)
We next seek to to determine which combinations of parameters best explain
the di↵erences between remission and relapse. For each model we look at
the parameter combinations that give rise to either outcome; this way we
propose the likely mechanisms which result in the di↵erent progressions.
Linear discriminant analysis provides a convenient way to do this by finding
a linear combination of parameters that best separates the two outcomes.
This is similar to PCA (used in Chapter 5) but is appropriate when the
variable of interest is discrete rather than continuous. The results of this
analysis are summarised in Figure 6.6. For both models M1 and M3, a very
good separation was found; it is interesting to note this separability since
each individual posterior distribution is broad.
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Figure 6.6: Linear discriminant analysis (LDA) predicts di↵erences between
models in how they control disease outcomes. (A) For each model, clear
separation between disease outcomes can be made (histograms, top). The
parameter contributions (coe cients) to the linear discriminant are shown
on a horizontal axis. For model M1, the healthy parameters are represented
by blue dots and the leukaemia parameters by orange dots; for model M3,
the pink dots designate the death rates. (B) Shown for M1 is a density
plot of ay against by with the location of remission outcomes marked in
blue and the relapse outcomes in red: using only these two parameters a
good separation is already achieved. We also show the posterior density
distribution of parameter e alone in case of remission (blue) and relapse
(red) – moderate separability is observed. For M3 we show the posterior
density distribution for each of the death rates and we see that for d2,
remission (blue) and relapse (red) can be well distinguished.
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For modelM1 we find that parameters ay, by and e explain most of the di↵er-
ences seen between disease outcomes. The pair of parameters contributing
the largest amount to the linear discriminant, (ay, by), describe growth and
di↵erentiation of LSCs and production of di↵erentiated leukaemia cells. In
the case of remission, both these parameters have to be su ciently low
for leukaemia cell production to be kept in check, whereas for relapse M1
requires ay > by, so that growth of LSCs can be maintained. Parameter
e, whilst not constrained for remission, should be relatively high for re-
lapse. This is required to produce the sharp peak in healthy di↵erentiated
cells. Overall for M1, we can say that in determining outcome, controlling
leukaemia species is more important than controlling healthy species.
This leads us to predict that disease outcome could be controlled by varia-
tion only in parameters related to LSC function. To test this we simulate
model M1 under relapse conditions until the onset of disease relapse and
study the e↵ect of varying ay. We see that by decreasing ay while keeping
all other parameters constant, we can stop relapse from occurring and the
patient goes back into remission, shown in Figure 6.7A. This intervention
– selectively suppressing the growth of LSCs – thus seems promising, but
is probably not yet possible to achieve clinically.
Performing a similar analysis for model M3, we see that a single parame-
ter, d2, explains most of the variation between outcomes (see Figure 6.6).
Relapse requires all of the di↵erentiation/death rates to be high in order to
produce the desired peak in healthy di↵erentiated cells from peaks in the
progenitor cell species. Contrastingly, for remission, d2 should be moderate
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Figure 6.7: In silico interventions predict that for M1 (but not M3) relapse
can be avoided. A. Response of model M1 to treatment intervention. Model
is simulated using the maximum a posteriori parameter for relapse until 19
months, at which point the LSC growth parameter (ay) is decreased from
0.92 to 0.07 and the model predicts that the patient returns to remission
(bold line). The dashed line represents the predicted level of BCR-ABL
without intervention. B. Response of model M3 to treatment intervention.
Model is simulated using the maximum a posteriori parameter for relapse
until 19 months, at which point the progenitor cell death parameter ( 2) is
decreased from 0.47 to 0.01. In this case the predicted time until relapse in-
creases, but the outcome is not changed. As above, the bold line represents
the intervention and the dashed line represents original relapse parameters.
or low. We observe that non-zero populations of partially di↵erentiated cells
(x2, y2) must be maintained (explaining the low value of d2) so that fully
di↵erentiated cells (x3, y3) can be produced under the control of parameters
cx and cy.
The parameters that are identified as important for discrimination here
all relate to the more di↵erentiated cell species. This is not surprising:
the data describe only dynamics at the di↵erentiated cell level and not
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the stem cell level, so we would expect parameters controlling stem cell
population dynamics to be less informative here. It is also worth considering
the direct impact that the di↵erent model constraints will have on the
inferred mechanisms of the models. Model M1 does not allow stem or
progenitor cell death, thus restricting the possible behaviours observed for
these species. Model M2, on the other hand, allows cell death but couples
the death rates for healthy-leukaemia species pairs that are at the same
hierarchical level. This limits the possible dynamics of these pairs of species
and constrains their behaviour.
6.5.5 Minimal descriptions of models M1 & M3
(model reduction)
In light of these di↵erences in system behaviour, the comparable quantita-
tive agreement between model and data (as revealed by Bayesian model se-
lection) and the absence of discriminatory data, we need to consider models
M1 and M3 from yet a di↵erent angle: robustness to the specification of the
model. Model M1 contains five species and model M3 contains eight; in any
case this is a vast oversimplification of the true extent of the haematopoietic
system. Here we consider the e↵ects of reducing the number of parameters
and the number of species within each model.
In modelM1 there are three species in the healthy and two in the leukaemia
lineage. Healthy progenitors are included because we know that the
haematopoietic system contains a number of layers between stem and dif-
ferentiated cells and we do not want to exclude these intermediate layers
6.5. Results and discussion 134
altogether. In the case of leukaemia, there is evidence to suggest that at
least a two-layered hierarchy exists, but not necessarily that intermediate
layers exist, so only two layers have been included here. A model with three
leukaemia species has been analysed previously and the qualitative changes
introduced by the addition of this species were found to be negligible and
do not impact on the overall model behaviour.
Model M3 has four layers of cell species for both the healthy and leukaemia
lineages, which Foo et al. (2009) describe as stem cells, progenitor cells, dif-
ferentiated cells and terminally di↵erentiated cells. Their justification for
this model hierarchy is based on the characterisation of the haematopoietic
lineage as described by Weissman and colleagues (Morrison et al., 1995;
Spangrude et al., 1988). Haematopoietic species do make up a multilevel
hierarchy, but whether this number of species is required in a model used to
analyse data for only the terminally di↵erentiated cell population is ques-
tionable.
To test this, we ran a similar posterior comparison analysis to that per-
formed above for reduced versions of M3 with only two or three layers in
the hierarchy. Once again, rather than directly study the posterior dis-
tributions obtained, we investigate trajectories simulated for parameters
sampled from the posterior. The results of this are shown in Figure 6.8.
Given the three variations we now have for model M3 (for both remission
and relapse cases), we can compare them and we see that the trajectories
obtained for the original and the reduced models behave similarly. For re-
mission we see that trajectories for the three- and four-layer models are very
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Figure 6.8: Dynamics of model species for reduced-form M models. Pre-
dicted evolution of each species for both outcomes (remission in A-B, re-
lapse in C-D) under two reduced versions of model M3: three-layer (A &
C) and two-layer (B & D) hierarchies, respectively. For each model and
each outcome, 1000 parameter sets have been sampled from the posterior
distribution and each line corresponds to the simulated trajectory for one
of these parameter sets.
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similar, so we could omit one layer without changing the model behaviour.
In going from three to two layers we do observe more pronounced changes:
now the dynamics of di↵erentiated leukaemia cells are constrained, as are
the dynamics of their parent (LSC) population (Figure 6.8B). These trajec-
tories show similarities to those obtained for model M1 after calibrating it
to the remission data. The shared feature between modelsM1 and two-layer
M3 is that the niche exerts its influence over all non-di↵erentiated cells; this
might explain the similarities seen here. The remaining di↵erence between
these models is the number of niche competitor cells: all species in M1 vs.
only stem cell species in two-layer M3 (see Figure 6.1). We thus suggest
that this could be a robust feature of niche competition models.
For relapse, the healthy and the leukaemia di↵erentiated cells follow re-
stricted trajectories in all versions of model M3. The populations of cells
giving rise to fully di↵erentiated healthy cells in each case (which can be
progenitors or stem cells) are now more tightly constrained by the data.
The parent population to di↵erentiated leukaemia cells in each case can
exhibit a range of behaviours without such restriction.
In summary, this analysis demonstrates that a hierarchy of four layers is
not necessary to capture the observed CML dynamics within the context of
model (or model family) M3. The main di↵erence between models M1 and
M3 is the level to which cells in the haematopoietic system experience the
influence of the haematopoietic stem cell niche. The version of model M3
with a two layer hierarchy thus naturally resembles the dynamics of model
M1, where di↵erentiation occurs inside the niche. To resolve the problem
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of discriminating between models M1 and M3 we thus need to be able to
probe the haematopoietic stem cell niche directly.
6.6 Conclusion
CML has been studied in great detail, and a number of successful models
describing di↵erent aspects of disease progression have been developed in
the past decade (Colijn & Mackey, 2005; Foo et al., 2009; Kim et al., 2008;
MacLean et al., 2013; Michor et al., 2005; Moore & Li, 2004; Roeder et al.,
2006; Werner et al., 2011). However, there remains uncertainty about the
cellular processes that control disease aetiology and outcome. Here we have
approached this question by comparing three models of CML dynamics and
their ability to explain clinical data on CML progression.
We used a Bayesian inferential framework and found that all of the models
can be fitted to data for both remission and relapse and receive the same
level of statistical support. Because of the limitations of the data we thus
have to adopt more detailed model analysis and model checking tools in
order to discriminate between these di↵erent mechanistic hypotheses.
Model M2, for example, can be ruled out as it requires exponential and
sustained growth of LSCs in order to explain the available data. The key
di↵erence between this and the other two models is that model M2 does
not allow for interactions in the stem cell niche but assumed that all cell-
types evolve independently. This suggests that cellular competition is an
important and perhaps crucial aspect of a model seeking to describe the
6.6. Conclusion 138
ecology of haematopoietic and leukaemia cells inside CML patients.
Despite the limited nature of the data our Bayesian framework allowed
us to analyse the remaining models in more detail, and we used simula-
tions from the posteriors to explore the behaviour of the di↵erent models
in patients exhibiting relapse and remission. Posterior distributions, even
though frequently broad, nevertheless can frequently give rise to constrained
behaviour of the di↵erent species modelled here. Crucially, our analysis has
allowed us to show the e↵ects that the niche can exert on disease progres-
sion: as more cell types — HSCs and LSCs reside necessarily inside the
niche micro-environment — are exposed or contribute to the cell popula-
tion dynamics inside the niche, model M3 increasingly resembles model M1.
If the niche does indeed extend its influence also over progenitor cells then
our analysis suggests that clinical outcome is determined by how e↵ectively
therapy targets LSCs. In M3 by contrast we found that the di↵erences be-
tween patients showing remission or relapse are less pronounced, with the
death rate of progenitor cells being the parameter exerting most influence
over a patient’s prognosis.
Haematopoiesis is a model system and CML is a model disease. Despite the
large body of knowledge gathered, and despite the successful treatments for
CML, there remain large gaps in our understanding of the cellular processes
that underpin this disease. Here we have identified mechanistic di↵erences
at the cellular level between di↵erent hypotheses of CML progression that
we hope will become experimentally testable as methods for probing the
HSC niche advance. The ability to map the haematopoietic system and
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its dynamics in vivo will almost certainly also benefit our understanding of
other haematological disorders.
Seven
Conclusions and future work
In this thesis we have used a variety of theoretical approaches to attempt
to learn more about the interactions between haematopoietic stem cells
(HSCs), the niche in which they reside, and cancer cells that can perturb
this system. Here we tie together the conclusions that we reached from each
chapter. We discuss briefly their short and longer term implications. We
also describe what we believe to be some of the most important or exciting
future research goals to pursue both theoretically and experimentally.
In Chapter 4 we studied stability properties of simple models of stem cell
dynamics under a new framework. We identified the ways by which systems
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that are more realistic – in the sense that their interactions are specified by
an underlying model, rather than at random – gain stability. This occurs
primarily through heterogeneity in the types of interaction between species,
and, to a lesser extent, through dependencies between interactions. We
studied a family of models that di↵ered in their number of lineage branches
and in their treatment of feedback. Our probabilistic framework for stability
analysis demonstrated that the fixed points of each model were always or
almost always stable for those fixed points with biologically interesting (i.e.
positive) values. This shows us that in the case of these models, and also,
we believe, more generally, stability depends less on the particular type and
strength of interactions and more on whether or not these interactions are
drawn from a distribution based upon a structured model.
From analysis of one model where two fixed points could be reached, we
saw how di↵erent parameter regimes characterise the two fixed points.
Prospects based on both mathematical and biological extensions of this
analysis are exciting. Mathematically, we move towards performing a global
multivariate bifurcation analysis, by characterising the di↵erent fixed points
in parameter space and delineating the boundaries between them. Biologi-
cally, we aspire to understand (and even control) how cell lineage branching
decisions are made. This is a desirable goal both for fundamental biology
and for designing new strategies to overcome disease such as leukaemia,
that results from misregulated cell growth within a certain branch of the
haematopoietic hierarchy. Another extension to the stability framework
that we use here will be to extend it so that numerical simulation yields
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similar results for the probabilities of stability in cases where analytical
expressions for the fixed points cannot be found.
In Chapter 4 we learned how stem cell models can be stable through general
principles that are not specific to the model. We also began to understand
how cell branching processes can occur. These models provide the inspira-
tion for the models developed subsequently, that build upon these simple
versions and consider additional process.
In Chapter 5 we introduce two new models that describe stem cell dynamics
within the niche in the case where leukaemia is also present. These models
treat the competition between healthy and diseased lineages in di↵erent
ways and we seek to infer desirable conditions within the niche, that is,
we study how leukaemia can be out-competed and healthy haematopoiesis
restored.
These two models are extensions of the models of Chapter 4, describing
the cellular processes that govern stem cell function. They also incorporate
concepts from ecological modelling, specifically Lotka-Volterra-type compe-
tition between species and mathematical treatment of the stem cell niche.
Due to di↵erent – and sometimes conflicting – definitions of the HSC niche,
we define it functionally rather than spatially; this allows us to account for
uncertain or as yet unknown niche e↵ects in our framework.
We fit these models to a qualitative outcome that requires the system to
maintain a viable healthy haematopoietic cell population that can drive
out the leukaemia cell species from the niche. In doing so we find that
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the most important parameters to achieve this correspond to growth and
maintenance of healthy cells – not the direct killing of cancer cells. We thus
propose that if it were possible to maintain a su cient healthy HSC popu-
lation this alone could already be almost su cient to overcome leukaemia.
We also suggest that focus on healthy HSC maintenance ought to become
a central aspect of any therapeutic regime. Both models share this finding.
We see that the second, more complicated model does not add extra insight
with regards to the questions that we address here, so we do not proceed
further with analysis of this model.
In Chapter 6 we continue to study questions of competition between healthy
haematopoietic cell species and leukaemia. We take the simpler model from
Chapter 5, introduce two new models from the literature and compare these
three models against clinical data for patients undergoing treatment for
chronic myeloid leukaemia. In doing so, we attempt to answer a distinct
but closely related question compared to the one of the previous chapter.
Where before we sought to understand how (theoretically) leukaemia could
best be eradicated from the HSC niche, here we want to know whether
di↵erent models can explain the data both of disease remission (moving
towards complete leukaemia eradication) and of disease relapse (a return of
disease following from initially successful therapy).
We discard one of the models because although it provides an equally good
fit to the data as the others, it does so only by unrealistic leukaemia stem
cell growth dynamics (unbounded exponential growth). Since this model
is the only one not to include explicitly the competition between healthy
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and leukaemia stem cells, we are led to suggest that this competition is an
important and perhaps crucial feature of models that seek to describe the
dynamics of chronic myeloid leukaemia.
Proceeding to analyse the two remaining models in light of the data and
with attention to the ecological description of cell interactions that they pro-
vide, we find that each makes distinct predictions regarding disease progres-
sion. One predicts that once treatment has begun there will be a transient
increase in the number of healthy progenitor cells. The same model predicts
that controlling the growth of leukaemia stem cells is the most important
factor in determining disease outcome (remission or relapse). The other
model, in contrast, predicts that controlling the death rate of progenitor
cells is most important in determining outcome. Testing these predictions
should enable us to invalidate one of these models, and perhaps provide
support for the other.
In addition to the experimental studies we hope to prompt from these re-
sults, we also highlight more and less important features of models of HSCs.
One of the more important features is a description of the competition be-
tween cellular species. One of the less important features is the addition
of extra progenitor cell populations in the hierarchy – especially given that
we do not currently have data describing these populations. We thus sug-
gest that wherever possible, models with fewer subpopulations should be
used until we are able to gather in vivo human data for the healthy and
leukaemia stem and progenitor cell species, not only in the blood but also
in the bone marrow.
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One exciting direction for future study is to extend the modelling of HSCs
using ordinary di↵erential equations (ODEs) to include detailed spatial in-
formation, such as using cellular automata. We include an outline of possi-
ble ways this could be accomplished in Appendix B.
Despite so much activity, there remains much to be understood about HSCs.
Here, their dynamics have been studied from a variety of angles. We have
made new predictions that can be tested experimentally and we have raised
new questions that we hope will advance the discussion on HSCs, their niche
and leukaemia.
Appendix A: Parameter
posterior distributions
Here we present the marginal posterior distributions for the parameters of
models that are inferred using approximate Bayesian computation. Parts
of these distributions were presented in the results of chapters 5 and 6; they
are given in full here for completeness.
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Figure A.1: Posterior distribution for model A. Based on fit to qualitative
outcome: leukaemia eradication and healthy haematopoietic cell species
survival. Marginal posterior distributions for each parameter are shown
along the diagonal and surface density plots for each pair of parameters are
given as heat maps.
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Figure A.2: Posterior distribution for model B. Based on fit to qualitative
outcome: leukaemia eradication and healthy haematopoietic cell species
survival. Marginal posterior distributions for each parameter are shown
along the diagonal and surface density plots for each pair of parameters are
given as heat maps.
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Figure A.3: Posterior distribution for model M1 under remission condition.
Marginal posterior distributions for each parameter are shown along the
diagonal and surface density plots for each pair of parameters are given as
heat maps.
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Figure A.4: Posterior distribution for model M1 under relapse condition.
Marginal posterior distributions for each parameter are shown along the
diagonal and surface density plots for each pair of parameters are given as
heat maps.
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Figure A.5: Posterior distribution for model M3 under remission condition.
Marginal posterior distributions for each parameter are shown along the
diagonal and surface density plots for each pair of parameters are given as
heat maps.
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Figure A.6: Posterior distribution for model M3 under relapse condition.
Marginal posterior distributions for each parameter are shown along the
diagonal and surface density plots for each pair of parameters are given as
heat maps.
Appendix B: Spatial models of
stem cell dynamics with
cellular automata
B.1 Overview
Cellular automata (CA) o↵er a stochastic, spatial, grid-based modelling
framework and their application to modelling biological systems has many
appealing characteristics. The development of CA to investigate stem cell
niche dynamics and competition is beyond the scope of this thesis but does
o↵er a very attractive avenue for future work. Here, we will briefly dis-
cuss two di↵erent CA pertinent to the biological problems that we have
been investigating. We will demonstrate how these can be developed in fu-
ture work and outline their potential advantages over deterministic (ODE)
models and their limitations.
B.2 Introduction
In Chapter 3 we introduced CA in our overview of modelling techniques.
We will not repeat that introduction here but give a brief reminder.
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CA were initially developed by von Neumann (1966), Wolfram (1983) and
others and describe the evolution of one or more types of agent on a grid
of lattice points. (These agents are usually called cells but we avoid this
name since they bear no relation to biological cells.) The grid defines the
model’s behavioural space; we consider 2D grids here but these methods
are easily extendible to 3D, given appropriate boundary conditions and
su cient computational resources.
The dynamics of CA are controlled by an update rule. Update rules can
be deterministic or stochastic as well as synchronous or asynchronous. here
we consider asynchronous stochastic update rules, which we think resemble
most closely the systems that we attempt to describe. Early work by John
Conway and others did use deterministic update rules to study the evolution
of CA that mimicked “life” in the sense that agents were governed by self
replication and death (Sigmund, 1993).
Consider the grid shown in Figure B.1, as a small portion extracted from a
larger grid. We construct an update rule based on the 8 nearest neighbours
of the central grid point, thus only these are shown. In this example we
have only one type of agent (red) and empty grid points are white. Based
on the number of neighbours, the agent can either die, replicate, or remain
in its place. These three options are shown in Figure B.1.
The rule used in Figure B.1 is the same as was presented as an example in
Chapter 3, namely,
1. if surrounded by less than four cells, divide, creating a new cell at a
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Grid before
update
Outcome
Agent dies Agent replicates No change
Figure B.1: Update rule for a CA based on nearest neighbours on a 2D
grid. Agents are shown in red and white denotes empty spaces. The focal
agent is in each case the one in the centre of the grid, surrounded by its 8
nearest neighbours. The top row shows three example grids that each lead
to a di↵erent outcome for the focal agent. The bottom row shows the same
grid after the update rule has been applied. See main text for a description
of the update rule.
free neighbouring grid point,
2. if surrounded by more than six cells, die
3. else, do nothing.
By defining rules that as best as possible represent the underlying biology,
and then simulating a model over some time period in order to observe how
the population of agents evolves, we can make new predictions about the
biological systems under investigation.
The agents in CA can correspond to many di↵erent phenomena. In biolog-
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ical modelling, they often represent cells of parts of cells. Here we consider
bijective CA where one agent = one cell; many other variations are possible.
In the next section we present two CA that address di↵erent questions
regarding the spatial organisation of stem cell populations.
B.3 Applications of cellular automata
B.3.1 A model of loss of stem cell self renewal
Haematopoietic stem cells (HSCs) gradually lose their self renewal capacity
through either activation from a quiescent state or di↵erentiation towards
specialised cells through multiple multipotent progenitor cell populations
(Wang & Wagers, 2011). It has been shown that spatial aspects a↵ect HSC
self renewal (Kiel et al., 2005; Lo Celso et al., 2009a; Wilson et al., 2007),
however, there remains much to be understood about the exact processes
of how self renewal capacity is lost (Wilson & Trumpp, 2006). Here, we
describe a CA that could be used to study loss of self renewal capacity
along an axis.
Shown in Figure B.2 is an example simulation of this model. Along the ab-
cissa is the cell position relative to the niche ‘wall’ – at 0 on this axis; along
the ordinate is shown spatial HSC occupation of the niche. We make the
assumption that as HSCs move farther away from the wall, they will gradu-
ally lose their self renewal capacity. We seek to model how this might occur
using di↵erent functions to describe the strength of interaction between the
niche and HSCs.
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The model can be simulated by imposing an update rule that allows HSCs
either to self renew or migrate away from the niche wall. In this example
dedi↵erentiation (HSCs moving to the left on the grid) is not allowed. The
update rule can be summarised as follows: if the niche strength (a decreasing
function along the abcissa) is above a threshold, the cell will not migrate
and divide with some probability, as long as there is free space to do so.
If this niche strength is below the threshold then the cell will migrate to a
free space one grid point further away from the niche wall, as long as there
is space to do so.
In the snapshots of CA evolution shown in Figure B.2, we see an illustration
of how the system might evolve. Depending on the definition of the niche
strength function, we might find that all the HSCs eventually leave the
niche wall begin to lose their self renewal capacity. Or instead, perhaps the
strength of the niche will be enough to maintain the majority of HSCs at
maximal self renewal capacity.
B.3.2 A competition model for healthy versus
cancer cells
In this application, we consider a competition model that shares character-
istics with the models studied in chapters 5 and 6, but with a description of
how cell location influences competition. This model can be used to study
how cancer arises in healthy tissue and to study requirements for cancer
to invade successfully rather than being outcompeted by healthy cells. We
can also look at the di↵erences in outcome between competition initiated
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Po
sit
io
n
Position relative to the niche wall
Time = 0 Time = 10 Time = 20 Time = 30
wall wall wall wall
Figure B.2: Simulation of HSC loss of self renewal dynamics. In this CA
the red agents are HSCs and the model describes how the HSCs lose their
self renewal capacity as they move away from the niche wall (the ordinate).
The update rule for HSCs encompassing cell replication and migration is
described in the text.
by a single cancer cell, and that initiated by a small group of cancer cells.
In this simple illustration we do not consider to which particular tissue
type the healthy and cancer cells belong: we refer to them generally. Each
cell type has its own update rule that depends on its neighbours. These
neighbours can now be one of two di↵erent cell types. We consider the case
where both cell types are growing surrounded by free space (analogous to
cells in a growth medium).
Figure B.3 shows an example simulation of the competition between cell
types. The update rule that governs this simulation can be summarised by
the general points:
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• healthy and cancer cells surrounded by a small number of other cells
can divide,
• healthy cells surrounded by roughly equal numbers of neighbouring
cells and free spaces can migrate,
• cancer cells surrounded by equal or greater numbers of neighbouring
cells than free spaces can migrate.
In this model no cells die. By giving cancer cells a migratory advantage
over healthy cells, we can study the competition dynamics and discover
(for example) the time taken until the cancer clone dominates the tissue.
Initial conditions were chosen such that a very small population of cancer
cells arise amidst healthy cells, shown at time = 0 in Figure B.3. The
system is then simulated with an asynchronous update rule for a specified
time period. Snapshots of the populations of healthy and cancer cells are
shown for three subsequent time points. From Figure B.3 we can see both
populations growing alongside one another and that the cancer population
quickly starts to overcome the healthy cells, due to its greater migratory
capacity.
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Time = 0
Po
sit
io
n
Time = 100
Time = 200 Time = 300
Position
Figure B.3: Simulation of spatial competition model for healthy and cancer
cells. Healthy cells are red, cancer cells are blue, and free space is white.
Initial conditions were chosen such that a small population of cancer cells
is surrounded by healthy cells. The number and location of healthy and
cancer cells are then shown for three subsequent time points.
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B.4 Discussion and Conclusions
The simple examples of CA given here serve as an illustration of the pos-
sibilities such models o↵er in attempting to understand biological systems.
Their intuitive design and relatively simple implementation make them
readily accesible to modellers who wish to perform grid-based simulations.
The myriad of subtle ways that CA can be modified represents both an
advantage and a drawback of these methods. Their flexibility means that
many di↵erent questions can be addressed by making changes to model
design. On the other hand, this flexibility can be limiting because in many
cases it might not be clear how the model should be constrained in order to
best reflect the biology under investigation. This might bring in an arbitrary
element to model design. For example, in the example rule given in the
introduction, why should the threshold for cell death be 7 neighbours, not
6 or 8? However, as data resolution improves, these challenges may become
surmountable.
Simulation of CA quickly becomes very expensive as the grid size or dimen-
sion increases, or the update rules become more sophisticated. This limits
current applications to real biological systems, which are many orders of
magnitude greater than the grid sizes most often used in CA modelling.
Despite the challenges, performing parameter inference with agent-based
models and fitting them to spatial data, either in vitro or in vivo, is be-
coming possible, an example is given by Sottoriva & Tavare (2010). The
challenges met in performing such inference are both methodological and
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biological. Methodologically we need ways to reduce computational cost,
probably through parallelisation, as well as measures of fit of model to data.
Biologically, we need spatiotemporal data of su cient resolution to perform
the inference. More and more relevant data are becoming available (Flesken-
Nikitin et al., 2013; Lane et al., 2011; Lo Celso et al., 2011; Me´ndez-Ferrer
et al., 2010; Simons & Clevers, 2011; Zhu et al., 2013), although automating
image analysis pipelines still represents a significant challenge.
CA are just one member of a family of agent-based models. We have fo-
cused on them here because we think they hold exciting potential for future
biological modelling, but other types of model might also be appropriate
for certain problems. For example, Cellular Potts models are a generalised
version of CA that include an energy function within the update rule that
is incorporated into the cellular dynamics (Scianna & Preziosi, 2013).
Hybrid modelling represents another attractive avenue for future research.
Here, agent-based models such as CA are combined with ODEs or PDEs
that describe continuous properties of the system. The addition flexibility
that this combination o↵ers can be advantageous to the modeller.
As a motivating example, consider the first CA application introduced
above, where HSC agents lose self-renewal capacity as they move away
from the niche wall. We might want to extend this example to include an
evolving population of niche cells, such as osteoblasts, that control the niche
strength. To do so we could use an ODE to model the size of the osteoblast
population (that depends on the size of the HSC population), and calculate
the niche strength (and thus update rule for HSCs) based on the osteoblast
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population trajectory. This assumes that there are many more osteoblasts
than HSCs, in most cases this will be a reasonable assumption.
In the above, we do not assume a spatial component to the osteoblast
dynamics, this could be included if we were to use a PDE rather than
an ODE to model osteoblasts and used, for example, a di↵usion term to
describe movement of osteoblasts.
The main advantage o↵ered here is that simulation times will be much faster
than if osteoblasts were to be treated as agents. Such an approach may
be appropriate in many cases, where there are di↵erent molecular/cellular
species numbers, or di↵erent timescales or length scales. Hybrid methods
thus o↵er the chance to include e↵ects on di↵erent scales, while maintaining
reasonable e ciency. In order to successfully implement such a model, it
must be ensured that the stochastic and deterministic components interact
correctly – this requires a suitable choice of timestep between each update.
It is also necessary to carefully consider the new interpretation of the system
that this hybrid model will o↵er. That is, to consider under what condi-
tions the division of model components into stochastic and deterministic is
appropriate, and when these assumptions might break down.
In this chapter we have outlined two ways in which CA can be used to
model biological systems, included because although they are outside the
main scope of this thesis they represent exciting possibilities for future
research. We hope that this outline may serve as a starting point for future
work, and look forward to discovering where such ventures may lead.
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